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Abstract 
Currently, even well-supported cognitive behavioral therapies to treat 
posttraumatic stress disorder (PTSD) suffer from consistent rates of dropout and non-
response to treatment, which represent barriers to dissemination and effective treatment.  
Research in anxiety disorders, including an initial group-based study with veterans 
suffering from PTSD, suggests that Motivational Interviewing (MI) may be an effective 
intervention for addressing issues of ambivalence and increasing readiness to change 
(RTC), resulting in decreases in dropout and non-response.  The present pilot study 
sought to assess the efficacy of augmenting Cognitive Processing Therapy (CPT) with 3 
sessions of MI in a sample of female interpersonal assault survivors (N = 17).  Within the 
MI study pilot sample, participants presented with a range in RTC) evidenced increases 
in RTC across the MI sessions (F = 3.48, p = .053), and demonstrated differential need 
for MI augmentation throughout the CPT sessions, as hypothesized.  Moreover, no 
participants dropped out during the MI sessions, and participants noted that they found 
the MI sessions helpful and drew on the MI prep sessions to stay motivated during 
treatment.  Contrary to hypotheses, MI did not significantly impact treatment 
expectations or fear of treatment.  The pilot results were also compared to a concurrently 
conducted comparison CPT trial (N = 92) as well as to the broader PTSD outcomes 
literature.  Interestingly, MI did not have a differential effect on RTC measures (F = 1.86, 
p = .093) as compared with the comparison study conditions.  Comparison results also 
indicate that MI did not substantially improve dropout rates (
2
 = .49, p = .782) or 
treatment engagement measures (F = 1.24, p = .290), and that MI+CPT participants 
evidence similar symptom outcomes to the comparison trial (F = .84, p = .541).  
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Similarly, MI study rates were at the high end for dropout and evidenced equivalent 
treatment outcomes, as compared to recent CPT trials.  Study limitations and clinical 
implications are considered. 
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Motivational Interviewing as an Augmentation to Increase Effectiveness in Cognitive 
Processing Therapy for PTSD: An Initial Trial 
A. Posttraumatic Stress Disorder Prevalence, Criteria, and Treatment 
Exposure to traumatic events is an unfortunately common occurrence with 
significant consequences for survivors.  Epidemiological study estimates that the majority 
of individuals will experience at least one traumatic event in their lifetime.  In a large-
scale study of cities in the southern United States, Norris (1992) found that 69% of 
people had experienced at least one trauma in their lifetime.  Similarly, in their nationally 
representative sample of over 8,000 adults Kessler et al. (1995) reported that 61% of men 
and 51% of women had experienced at least one traumatic event in their lifetime.  
Moreover, survivors of trauma often experience significant, negative sequelae of the 
event, including medical costs, occupational and other functional impairment, and 
psychological burden (Kessler, 2000).   
Post-traumatic stress disorder (PTSD) is the most common psychiatric diagnosis 
following a trauma (Resick, 2001).  According to diagnostic criteria set out in the 
Diagnostic and Statistical Manual of Mental Disorders, 4
th
 edition (DSM-IV; APA, 
2000), PTSD develops after the experience of a traumatic event, which involves threat to 
life or integrity to self or others that is experienced with fear, helplessness, and/or horror.  
PTSD is further defined by three clusters of symptoms: 1) re-experiencing symptoms, 
including nightmares, flashbacks, and intrusive memories; 2) avoidance and numbing 
symptoms, characterized by avoidance of trauma-related cues, emotional numbing, social 
withdrawal, and restricting general activities; and 3) hyperarousal symptoms, marked by 
features such as hypervigilance, anger and irritability, sleep impairment, and 
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concentration deficits.  To meet clinical criteria, these symptoms must cause significant 
distress or impairment in functioning.  Survivors with PTSD typically experience 
impairments across several major domains of functioning; thus treatment for this chronic 
condition is critically important in re-establishing functioning and regaining quality of 
life (Galovski, Sobel, Phipps & Resick, 2005). 
Survivors of interpersonal trauma are at particularly high risk, and in fact, are 
more likely than the survivors of any other trauma type to develop PTSD (Kessler et al., 
1995).  Exposure to interpersonal trauma is a relatively common experience.  In a survey 
of 2,200 participants conducted in the Detroit area, Breslau et al. (1998) found that the 
lifetime prevalence rate of interpersonal violence exposure was 38%.  In a national 
sample of 4,008 women, 13% reported at least one completed rape, 14% reported an 
attempted rape or molestation, and 10% reported a serious physical assault.  This study 
also found that 32% of rape survivors, 31% of sexual assault survivors, and 39% of 
physical assault survivors developed PTSD (Resnick, Kilpatrick, Dansky, Saunders, & 
Best, 1993).   
Independent of the type of trauma, females appear to be at a higher overall risk of 
developing PTSD after a traumatic event.  An epidemiological study estimates that 20% 
of women exposed to trauma developed PTSD, as compared to only 8% of men (Kessler 
et al., 1995).  Additionally, a recent meta-analyses found that women were at higher risk 
for PTSD across every type of trauma (Tolin & Foa, 2006).  Thus, it has been proposed 
that female survivors of interpersonal trauma make up the largest percentage of overall 
PTSD cases (Calhoun & Resick, 1993).   
Fortunately, there now exist several well-supported psychotherapies for PTSD 
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(Foa, Keane, Friedman, & Cohen, 2009).  Specifically, cognitive behavioral therapies 
(CBTs) have demonstrated strong empirical support and are the only group of therapies 
approved as empirically supported treatments for PTSD.  As a group, these treatments are 
highly effective, with several recent meta-analyses finding consistent empirical supported 
for trauma-focused CBTs.  In a meta-analysis of 26 randomized controlled trials (RCTs), 
Bradley et al. (2005) found that 67% of individuals who completed a trauma-focused 
CBT lost their PTSD diagnosis.  Similarly, a meta-analysis of 38 RCTs supported 
trauma-focused CBTs as superior to waitlist (WL) and non-specific/supportive 
psychotherapies with equivalent results among different CBTs (Bisson et al., 2007).  
Overall, each of the trauma-focused CBTs provides survivors with equally effective 
therapeutic outcomes (Ehlers et al., 2010). 
Cognitive processing therapy (CPT; Resick, Monson, & Chard, 2010) is one such 
CBT, which was initially developed to treat symptoms of PTSD and depression and first 
tested in a sample of female survivors of rape and sexual assault.  CPT is primarily a 
cognitive therapy, which emphasizes cognitive techniques including Socratic questions to 
accurately integrate assault-related information with previously existing belief systems 
(Resick, Monson, & Rizvi, 2008).  The therapist assists the survivor in resolving 
assimilated and over-accommodated thoughts, or stuck points, resulting from the trauma 
by collaborating with the patient in identifying and challenging the stuck points and 
developing more accurate and helpful alternate thoughts (Resick et al., 2010).  When 
stuck points are resolved, manufactured emotions (caused by the inaccurate thoughts) 
necessarily disappear.  CPT also includes a written narrative, in which clients write a 
narrative of their worst traumatic memory and are asked to review it both in session and 
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at home.  The written narrative in CPT is thought to differ from exposure therapies in that 
it relies on the assumption that the processing of natural emotions connected to the fear 
structure allows these emotions to dissipate and is not believed to rely on habituation 
(Cahill, Rothbaum, Resick, & Follette, 2009; Resick, Monson et al., 2008).  Thus, CPT 
results in the eventual resolution of both primary and secondary emotions connected to 
the trauma.   
CPT has been tested in seven RCTs with survivors of interpersonal assault and 
military traumas, with comparable results to other trauma-focused CBTs.  Resick et al. 
(2002) initially compared CPT to prolonged exposure (PE), the leading PTSD treatment 
at the time, and a minimal attention condition in a sample of 171 female rape survivors.  
Results of this trial indicated that both active treatments produced large effects on PTSD 
and depressive symptoms, which were maintained at a 9-month follow-up.  The active 
treatments did not significantly differ on tested outcomes, except that CPT demonstrated 
superior outcomes compared to PE on a measure of trauma-related guilt at post-treatment 
and 9-month follow-up and with respect to health-related concerns (Galovski, Monson, 
Bruce, & Resick, 2009).  Resick et al. (2008) then completed a dismantling study to 
examine the effectiveness of the unique theorized components of CPT.  The study 
randomized 150 female survivors of interpersonal violence to receive 12 individual 
therapy sessions of either original protocol CPT, CPT-C (no written narrative), or written 
accounts only (WA).  Results indicated that the treatment conditions were equally 
effective in reducing PTSD and depressive symptoms, as well as anger, guilt, anxiety, 
and shame at the end of treatment.  However, the conditions differed during the course of 
treatment, such that CPT-C participants reported a faster reduction in symptoms than the 
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WA participants.  
Five other RCTs have been conducted to extend the literature regarding the 
flexibility and effectiveness of CPT.  Chard (2005) compared the efficacy of a group 
format of CPT with a minimal attention condition for 71 female child sexual abuse (CSA) 
survivors.  This study employed 17-weeks of group therapy coupled with 9-weeks of 
concurrent individual treatment for processing the written narrative.  Results from this 
trial showed large effect sizes when CPT was compared with minimal attention on PTSD, 
depressive, and dissociative symptoms; these differences were maintained at 1-year 
follow up.  However, this study uniformly extended treatment for CSA survivors, thus the 
necessity of the extended length of CPT was yet unknown.  In an effort to test the 
flexibility of this robust protocol, Galovski and colleagues (2012) administered a variable 
length of CPT to male and female physical and sexual assault survivors, dependent upon 
individual treatment progress.  This study found that the majority of survivors met good 
end-state criteria (including PTSD-negative status with low scores for PTSD and 
depression) prior to the end of the 12-session protocol and that treatment gains were 
maintained at 3-month follow-up regardless of the number of sessions necessary to meet 
good end-state functioning. 
Monson and colleagues’ (2006) extended analysis of CPT to military-related 
PTSD.  Participants were 60 veterans (90% male; 80% Vietnam era), randomized to 
either 12 individual CPT sessions or to CPT following a 10-week WL.  CPT was again 
superior to WL, with CPT participants evidencing large effect size changes on PTSD and 
general anxiety symptoms, as well as trauma-related guilt and global psychosocial 
functioning, with a trend for improvement on depressive symptoms in the CPT condition 
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as well.  This result has been replicated in an Australian veteran sample, wherein CPT 
was again superior to WL at post-treatment and follow-up (Forbes et al., 2012).  Suris 
and colleagues (2013) similarly found large effects of CPT on PTSD and depressive 
symptoms within a sample of military sexual trauma survivors.  Overall, results from this 
successful empirical career indicate that CPT is as effective as other leading trauma-
focused CBTs in alleviating the symptoms of PTSD, as well as other concurrent clinical 
concerns, and in increasing global psychosocial functioning.  Moreover, CPT appears to 
be effective when administered in both group and individual formats, with and without a 
written narrative, for survivors of a range of traumatic experiences.   
 
B. Differential Responses to PTSD Interventions 
Although CBTs for PTSD, including CPT, have been shown to be effective in 
producing statistically and clinically significant change for PTSD positive trauma 
survivors, not all survivors benefit equally from the currently available treatments.  
Clients who seek treatment for PTSD using CBTs experience a range of outcomes, 
including successful therapeutic outcomes (i.e., the amelioration of PTSD symptoms and 
increase in global functioning) in the majority of survivors, as well as non-optimal 
responses, including premature dropout from treatment and non-response to treatment 
(i.e., a lack of change in PTSD symptoms during treatment).  All CBTs for PTSD have 
some rate of dropout, ranging as high as 54%, but consistently 20% or above in the 
majority of studies (Bradley et al., 2005; Imel, Laska, Jakupcak, & Simpson, 2013; 
Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008), as well as some percentage of 
non-response to treatment, ranging as high as 50% in some studies, and averaging 33% 
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across studies (Bradley et al., 2005; Schottenbauer et al., 2008).  In fact, dropout and non-
response to treatment have been identified as two of the most critical barriers to the 
dissemination and effectiveness of these otherwise effective CBTs (Cahill & Foa, 2004).   
Just as the range of current CBT treatments have similar effectiveness, the group 
as a whole also appears to suffer from some portion of non-optimal treatment responses.  
Reviews of trauma-focused CBTs have found no consistent differences in rates of 
dropout and non-response between therapy types (Ehlers et al., 2010; Hembree et al., 
2003), indicating that attrition and non-response are issues universal to empirically 
supported CBTs for PTSD and are not unique to a particular mode of treatment.  As such, 
a logical avenue to address issues of non-optimal response to PTSD treatment is through 
the identification of predictors of dropout and non-response.   
Predictors of Differential Response 
A review of the literature reveals multiple factors are associated with differential 
outcomes for PTSD following CBT, which could potentially be utilized to improve 
outcomes.  First, several therapy process-related factors emerge as treatment response 
predictors.  Low client ratings of treatment credibility predicted dropout (Taylor, 2004) 
and non-response to treatment (Tarrier, Sommerfield, Pilgrim, & Faragher, 2000), with 
the latter study also indicating low therapist ratings of client motivation as a predictor of 
non-response to treatment.  Longer duration of therapy has been linked with poor 
response to treatment (Tarrier et al., 2000).  Conversely, therapeutic alliance (Cloitre, 
Chase Stovall-McClough, Miranda, & Chemtob, 2004; Knaevelsrud & Maercker, 2007; 
Najavits, Weiss, Shaw, & Muenz, 1998) and homework compliance (Scott & Stradling, 
1997) are largely associated with positive treatment outcomes.  However, this literature is 
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not conclusive, with a separate study finding no differences between partial responding 
and full responding treatment completers on homework compliance, total session 
attendance, or therapist or group effects (Taylor et al., 2001).  These results may differ 
due to methodological issues, as the latter study assessed only MVA survivors and 
analyzed differences between statistically derived clusters of treatment responders, as 
opposed to continuous PTSD outcomes.   
Several facets of initial PTSD presentation also predicted dropout and non-
response.  More severe PTSD symptoms predicted dropout (Bryant et al., 2008; Chard, 
2005; Foa, Rothbaum, Riggs, & Murdock, 1991; Marks, Lovell, Noshirvani, Livanou, & 
Thrasher, 1998) and non-response (Hembree, Street, Riggs, & Foa, 2004; Owens, Chard, 
& Cox, 2008; Taylor, 2003, 2004; van Minnen, Arntz, & Keijsers, 2002), with two 
studies relating higher avoidance symptoms to dropout (Bryant et al., 2007) and longer 
duration of PTSD symptoms to non-response to treatment (van Minnen et al., 2002).  
Some types of anger were associated with non-response to treatment (Foa, Riggs, Massie, 
& Yarczower, 1995; Forbes, Creamer, Hawthorne, Allen, & McHugh, 2003; Forbes et 
al., 2008; Pitman et al., 1991; Taylor et al., 2001), though these findings are quite mixed 
with many studies failing to replicate this result (Cahill, Rauch, Hembree, & Foa, 2003; 
Galovski, Elwood, Blain, & Resick, in preparation; Rizvi, Vogt, & Resick, 2009).  A 
recent finding suggests that anger may interact with PTSD severity to predict treatment 
response (Owens et al., 2008), possibly explaining some of these conflicting results.   
Other clinical features have also been linked to outcomes.  Depressive symptoms 
(Bryant et al., 2008) and catastrophic thinking (Bryant et al., 2007) were associated with 
higher rates of dropout, but depression yielded very mixed results in predicting non-
 MI to Augment CPT   12 
 
response to treatment (Rizvi et al., 2009; Tarrier et al., 2000; Taylor et al., 2001).  
However, several clinical correlates of PTSD and depression were cited as predictors of 
non-response in individual studies, including higher suicidality (Tarrier et al., 2000), 
hopeless cognitions (Owens et al., 2008), and a sense of alienation or permanent change 
(Ehlers et al., 1998).  Similarly, guilt and shame predicted non-response to treatment 
(Owens et al., 2008; Pitman et al., 1991; van Minnen et al., 2002), but again support was 
mixed (Rizvi et al., 2009; Taylor et al., 2001).  Both GAD diagnosis (Tarrier et al., 2000) 
and higher levels of pre-treatment anxiety (Hembree, Marshall, Fitzgibbons, & Foa, 
2001) predicted non-response to treatment in a single study each, and higher pre-
treatment alcohol use predicted dropout (Riggs, Rukstalis, Volpicelli, Kalmanson, & Foa, 
2003; van Minnen et al., 2002).  Each of these predictors illuminates a potential area for 
enhancing treatment results. 
The Role of Ambivalence in PTSD 
Ambivalence is an important consideration in the outcomes of PTSD treatments 
and is a notorious factor presenting clinical challenges in PTSD work (Resick, Monson et 
al., 2008).  Unfortunately, this important factor has been relatively neglected in the PTSD 
literature.  Moreover, researchers vary in their use of this clinical term, and the specific 
connection between ambivalence and PTSD-related constructs has not been well defined.  
In their comprehensive review of the discussion of ambivalence across psychotherapy 
literatures, Engle and Arkowitz (2006) define ambivalence as “movements toward 
change as well as movements away from change” (p. 3).  Westra and Dozois (2008) 
utilize a similar definition in their discussion of ambivalence in anxiety disorders, “one 
wants change, yet one resists change simultaneously,” (p. 30).  Thus, ambivalence is 
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defined both in terms of behaviors that become apparent in therapy and an underlying 
internal process.  In both definitions, the authors concur that ambivalence may be about 
the change itself or about the methods of change (process), and may take many forms 
(behaviors), including not coming to sessions, not completing out of session practice, or 
not fully engaging while in session (Engle & Arkowitz, 2006; Newman, 2002).  
Interestingly, these ambivalent behaviors closely match several of the process factors 
found to predict differential outcomes for trauma focused CBTs. 
Within PTSD specifically, Resick and colleagues (2008) note that ambivalence 
about therapy may stem from wanting help, while simultaneously grappling with issues 
around trust, shame, trauma-related fear, and PTSD-driven avoidance of trauma-related 
stimuli (e.g., discussions of the traumatic experience in therapy), the balance of which 
leads to ambivalent behavior.  Thus, Resick et al. note specific PTSD related clinical 
features (e.g., avoidance and trust concerns) that may contribute to clients’ internal 
ambivalence process (i.e., wanting and not wanting change, above) and produce 
behaviors indicative of ambivalence (e.g., including not coming to sessions, not 
completing out of session practice, or not fully engaging while in session, above).  This 
ambivalence framework can be expanded to address the negative PTSD treatment 
outcomes predictors reviewed above.   
The role of ambivalence can be seen in the symptom-related factors that predict 
non-optimal response.  Specifically, as Resick et al. (2008) allude to in their work, many 
of the symptoms and related features of PTSD contribute to distress, that causes clients to 
want change, but also produce factors making engagement in the change process difficult.  
For example, higher PTSD symptoms indicate higher levels of PTSD-driven avoidance, 
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which may increase ambivalence around discussing the trauma in therapy.  Similarly, 
alcohol use has been linked as an avoidant coping strategy (Ullman, Filipas, Townsend, 
& Starzynski, 2005), possibly indicating decreased readiness to change (RTC) and higher 
ambivalence about change.  Anger, guilt, and shame have also been discussed as creating 
barriers to treatment engagement through defensive blocking, mistrust, and increased 
avoidance of trauma-related topics (Forbes et al., 2008; Resick, Monson et al., 2008).  
Likewise, clients with hopeless or catastrophizing cognitive styles or those who perceive 
a sense of permanent damage may believe that therapy may not work for them, that they 
cannot meet the demands of treatment, or that they are too damaged to be helped (Bryant 
et al., 2007; Ehlers et al., 1998); they may understandably have less motivation for 
change and experience more ambivalence.  Each of these PTSD related features could 
contribute to ‘movements away from change,’ thus contributing to the ambivalence 
process and behaviors. 
The process factors reviewed may also indicate a role for ambivalence in 
predictors of non-optimal PTSD treatment outcomes.  As was noted in the larger 
literature, the internal process of ambivalence may be evident in multiple behaviors 
throughout the therapy process, such as therapy attendance and overall engagement 
(Engle & Arkowitz, 2006; Newman, 2002).  Similar behaviors have been noted as 
predictors of poor outcome in PTSD, though they have not been discussed specifically as 
ambivalence.  For example, Tarrier and colleagues (2000) noted that longer duration of 
therapy, more missed sessions, and longer length between sessions may be “proxy 
markers which reflect a patient’s avoidance of therapy through irregular attendance,” (p. 
199).  One could further conclude that these behaviors of engaging partially in treatment 
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mark a desire both to engage and to avoid, or an ambivalent approach.  It is also likely 
that lower perceived treatment credibility and patient motivation may be early markers of 
ambivalence toward treatment as perceived by the client and therapist, such that 
ambivalent clients might be more skeptical of the treatment and therapists might see 
ambivalence as low motivation.  Not surprisingly then, higher alliance ratings, consistent 
attendance, and out of session practice of therapy skills, which may indicate lower 
ambivalence and avoidance, are largely linked to better treatment outcomes.   
In sum, the predictors of non-optimal treatment responses in PTSD may be 
connected to ambivalence processes in important ways.  PTSD clinical features (PTSD 
symptom severity and avoidance symptoms, anger, depressive symptoms, suicidality, 
catastrophic thinking, hopeless cognitions, a sense of alienation or permanent change, 
guilt, shame, general anxiety, and alcohol use) may contribute to the internal ambivalence 
process, or the simultaneous wanting and resisting of change, by creating distress and a 
desire to change as well as factors producing fear of change or treatment, disbelief that 
treatment will work, etc.  Similarly, process variables discussed in PTSD treatment 
outcomes (low treatment credibility, low motivation, inconsistent attendance, and 
reporting of logistic barriers) may serve as markers of the ambivalence process and 
indictors of a need to target RTC.  Conversely, higher alliance ratings, consistent 
attendance, and out of session practice of therapy skills are behaviors that may indicate 
lower ambivalence toward the therapy process.  These predictors of differential treatment 
responses to CBTs for PTSD represent important clinical targets and avenues for 
potential treatment enhancement. 
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C. Motivational Interviewing 
MI is a therapeutic approach that specifically targets client ambivalence, 
decreases attrition, and increases therapeutic engagement (Hettema, Steele, & Miller, 
2005).  This intervention was developed by Miller and Rollnick (1991; 2002) and initially 
showed promise in producing change among substance using populations.  Over the 
course of the last few decades, MI has been successful in increasing treatment response in 
a range of clinical presentations, including substance use disorders, eating disorders, 
several anxiety disorders, and depression (Arkowitz, Westra, Miller, & Rollnick, 2008; 
Federici, Rowa, & Antony, 2010).  Importantly, however, MI’s focus is on producing 
change in clients’ readiness and motivation to change, and not on change in a specific 
problem area per se.  As such, MI may provide an alternative conceptualization and novel 
treatment approach to address factors contributing to ambivalence that lead to suboptimal 
treatment responses in CBT for PTSD.   
MI is a unique therapeutic approach that combines a client centered and directive 
therapeutic style.  Built upon the Rogerian, person-centered approach, MI seeks to 
enhance clients’ own motivation for change by resolving ambivalence (Arkowitz & 
Miller, 2008).  The MI spirit is described as collaborative, not authoritarian; evocative, 
not installing/prescriptive; and honoring client autonomy (Rollnick & Miller, 1995).  
Using this therapeutic spirit as a foundation, four specific principles are employed to 
achieve change in intrinsic motivation: express empathy, develop discrepancy, roll with 
resistance, and support self-efficacy.  The first principle, expressing empathy, is critical 
to the client centered, collaborative relationship, as well as to the change process.  Here 
the therapist seeks to understand clients’ views of their world and problem areas, 
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allowing the therapist to understand clients’ motivations both for and against change.  
Once this understanding is established, the therapist is able to begin developing 
discrepancy.  This principle rests on the assumption that individuals experience 
discomfort when their behaviors and values are not congruent with one another.  Thus, 
the therapist seeks to reflect discrepancies and to elicit change talk, or arguments for 
change, from clients.  Conversely, resistance to change is also seen as natural part of the 
change process from the MI stance.  As such, arguments against change, or sustain talk, 
are accepted with empathy and understanding.  In this way, the therapist is able to roll 
with resistance, express empathy, and align with clients, rather than providing judgment 
that could amplify client ambivalence.  Finally, the therapist seeks to support clients’ 
self-efficacy for change, thus eliciting and confirming both clients’ internal motivation 
for change and their belief in their ability to make desired changes, with the goal of 
eliciting increasing verbal commitment to behavior change from the client.   
As noted, MI has been efficaciously applied to a broad range of clinical 
presentations and concerns.  The majority of studies to date have focused on substance-
related disorders, eating disorders, and health behaviors (Hettema et al., 2005; Lundahl, 
Kunz, Brownell, Tollefson, & Burke, 2010).  Initial support for several other areas of 
psychiatric concern, including anxiety and depressive disorders, has recently emerged 
(Arkowitz et al., 2008).  However, MI-based intervention has only been applied to 
motivation to change PTSD in two initial studies (Murphy, Cameron et al., 2004; 
Murphy, Thompson, Murray, Rainey, & Uddo, 2009).  As such, a discussion of the 
potential efficacy of MI for PTSD must draw from the larger MI literature to inform 
potential PTSD interventions. 
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Several general conclusions can be drawn regarding MI’s effectiveness across 
areas of treatment studied thus far.  In their meta-analytic review of 72 studies, Hettema 
and colleagues (2005) noted large effect sizes for increased treatment engagement, 
retention, and adherence when MI was added as a precursor to treatment protocols, which 
the authors conclude is at least partially mediated by the effects of MI on increasing 
treatment adherence and treatment retention.  Additionally, these authors note that MI’s 
effects appear to be more lasting when paired with an active treatment then when used 
alone.  In a subsequent review, Lundahl and colleagues (2009) found that MI appears to 
be equally effective for individuals at all levels of distress (across all reviewed problems 
areas).  In contrast, research within the area of anxiety treatment with MI has found more 
benefit from MI among those with higher initial symptom severity (Westra & Dozois, 
2008).  Additionally, Lundahl et al. noted that MI provided in an individual format was 
more effective than group formats and proposed that this may be related to therapeutic 
alliance being central mechanism of change in MI.  Finally, in a review of 19 MI studies, 
the use of a decisional balance exercise, in which the client weighs the pros and cons of 
changing, was the only specific technique to predict better outcomes (Apodaca & 
Longabaugh, 2009).  In sum, it appears that MI is well supported across a range of 
problem areas, but that the specific format of the treatment may impact the effectiveness 
of the outcomes.   
Transtheoretical Model 
Although independently developed, MI overlaps in meaningful ways with 
Prochaska and colleagues’ (2002; 2010) transtheoretical model (TTM).  Both theories 
hold that: 1) change is a process, 2) individuals approach the change process with 
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differing levels of readiness, and 3) ambivalence is a natural part of the change process.  
The stages of change (SOC) extend upon these general premises and posit that there are 
six specific, non-linear stages of the change process: pre-contemplation, contemplation, 
preparation, action, maintenance, and termination (Prochaska & Norcross, 2002).  
Individuals in pre-contemplation do not intend to change and may not see that they have 
a problem.  In contemplation, the individual is aware of the problem and may be 
considering change, but is not committed to change.  During preparation, the individual is 
aware of the problem and is planning to make change in the near future.  Not 
surprisingly, in the action stage the individual engages in behavior change.  The 
maintenance phase involves the consolidation of gains and preparation for maintenance 
of gains and prevention of relapse.  Finally, the termination stage involves the completion 
of the change process, in which the individual no longer needs to work to prevent relapse.  
Previous research has used the SOC, or RTC, to operationalize the change process and to 
understand the impact of client SOC on the therapeutic process.  This use of the SOC has 
also been applied to evaluate the efficacy of MI. 
The TTM also outlines several other interwoven components designed to support 
a more complex and comprehensive understanding of the transcendent factor of 
individual psychotherapy models.  One central aspect of the larger model is the pros and 
cons of changing, or decisional balance.  The pros and cons of change are a natural 
decisional balance used by individuals in considering change.  This aspect of the model 
highlights the need to assess both positive and negative aspects of change, reminiscent of 
a decisional balance used in MI.  The TTM posits that the pros of changing increase and 
cons decrease as the individual progresses through the SOC. 
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A note on terms.  Several terms are used inconsistently throughout these 
literatures to discuss issues related to motivation, ambivalence, and the change process, 
making accurate conceptualization and measurement of these constructs a challenge at 
present.  As already noted, stages of change (SOC) and readiness to change (RTC) are 
used interchangeably to describe an individual’s place in the change process.  The term 
motivation for change is also used in this way; however, the larger literature ascribes 
unique elements to motivation per se.  Indeed, DiClemente and Velasquez (2002) 
describe motivation as “what provides the impetus for the focus, effort, and energy 
needed to move through the entire process of change,” (p.  202).  So, although 
ambivalence is often thought of as a lack of motivation, it can more accurately be thought 
of as motivation for more than one action simultaneously (Miller & Rollnick, 2002).  
Thus the goal of MI is to build motivation for change (or increase the pros of change) 
versus the status quo (or the cons of change), thereby reducing ambivalence.  As such, 
SOC/RTC are related to, but not interchangeable with, motivation and ambivalence; 
however, their measurement is often used as an indicator of ambivalence.  Theoretically, 
ambivalence should be manifest when individuals are in lower stages of change (e.g., pre-
contemplation and contemplation) and resolve as individuals prepare and take action.  
Conversely, motivation for change should build as one resolves ambivalence and moves 
toward the desired change.   
 
D. Initial Research Investigating the Effectiveness of MI for PTSD 
As discussed above, MI has demonstrated empirical success in preparing 
individuals with a variety of mental health concerns for change (Arkowitz & Burke, 
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2008; Hettema et al., 2005; Lundahl & Burke, 2009).  However, research using MI as a 
complement to trauma-focused PTSD therapies is limited.  Only two studies have 
examined the utility of an MI-based protocol for PTSD.  A single other study, and a 
subsequent re-analysis, investigated the applicability of the TTM to the change process 
within PTSD.   
Murphy and colleagues developed the motivation enhancement (ME) protocol for 
veterans using MI techniques and rationale to help veterans identify problems they might 
want to change and issues that may be getting the way of their change process (Murphy 
& Rosen, 2006).  The ME protocol consists of four, 90-minute sessions comprising four 
steps: psychoeducation, comparison to the average guy, a pros and cons decisional 
balance, and roadblocks identification.  The protocol uses these stages to examine a host 
of concerns the veteran has listed as might haves, definitely haves, or definitely don’t 
haves (e.g., social withdrawal, nightmares, etc.), with the goal of identifying problems the 
veteran does have and would like to change in subsequent treatment.  In an initial study 
of 243 participants examining the utility of ME, Murphy and colleagues (Murphy, 2008; 
Murphy, Cameron, Sharp, & Ramirez, 1999; Murphy, Cameron et al., 2004; Murphy, 
Rosen, Thompson, Murray, & Rainey, 2004; Murphy & Rosen, 2006; Murphy, Rosen, 
Cameron, & Thompson, 2002) found that participants reclassified 40% of the problems 
initially listed as might haves to definitely haves or definitely don’t haves, with a majority 
of PTSD-related problems being reclassified to definitely haves.  The authors conclude 
that these changes indicate an amelioration of ambivalence toward these problem areas.   
As a second phase to their research, the Murphy group assessed the utility of the 
ME protocol as a preparation for a comprehensive outpatient PTSD program (Murphy et 
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al., 2009).  In this study, 115 veterans were randomly assigned to 4 sessions of 
psychoeducation or PTSD motivational enhancement (PME) beginning in their second 
month of a 12-month multi-focus treatment program.  The investigators aimed to assess 
group differences in attrition, session attendance, problem recognition, consideration of 
change, and PTSD treatment relevance, hypothesizing that the PME group would 
perform better than the psychoeducation group in all areas.  Assessments were conducted 
immediately prior to the first PME/psychoeducation session and immediately after the 
fourth session.  Symptom changes following completion of the full treatment program 
were not reported.   
Although the authors’ ambitious hypotheses were not fully supported, results lend 
some initial evidence for the utility of MI in enhancing PTSD treatment outcomes.  
Specifically, the investigators reported that the PME group changed a significantly higher 
proportion of their might have problems to definitely haves and demonstrated changes on 
multiple treatment attitude items (3 out of 7 items; e.g., “I have to consider what people 
say to me when they give me feedback” and “Comparing myself to guys my age who 
don’t have PTSD will be helpful”, and not “I plan on getting more help for my 
problems”), increased their perception of treatment relevance (1 out of 5 items; e.g., “I 
am satisfied with this particular group” and not “This group relates to my particular 
problems”).  PME participants also had higher program attendance and longer attendance 
of groups post intervention than the psychoeducaton group.  As such, these results 
suggest that this program made initial steps in addressing some predictors of non-optimal 
treatment outcomes, specifically, increasing program attendance, treatment credibility, 
and attitudes toward treatment.  Moreover, participants in PME appear to have better 
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recognition of their trauma-related problems, possibly increasing motivation to work on 
these areas in PTSD treatment.  Contrary to expected results, RTC as measured by the 
University of Rhode Island Change Assessment (URICA; McConnaughy, Prochaska, & 
Velicer, 1983) did not differ between the two groups and several items on other measures 
also failed to reach significance in between group tests.   
Although the studies conducted by the Murphy group represent important initial 
attempts to investigate the utility of MI for PTSD, there are several limitations to their 
work thus far.  In their initial assessment study, the authors conclude that the 
reclassification of a might have problem indicates a resolution in ambivalence; however, 
the recognition of a problem does not indicate the resolution of ambivalence to change 
that problem.  Further, in their 2009 intervention study, the psychoeducation and PME 
groups did not differ on RTC post-intervention.  The authors describe this lack of 
findings as “perplexing,” and posit “attentional, cognitive, and reading problems” and 
“trouble remembering specific instructions (especially during a lengthy assessment)” (pp. 
274-275) as potential sources of error leading to this outcome.  This explanation is 
unlikely to address this finding given that both groups underwent the same assessment 
procedures.  It is noteworthy that the researchers measured RTC regarding two specific 
problems, as opposed to general trauma issues as has been employed by other authors 
(Hunt, Kyle, Coffey, Stasiewicz, & Schumacher, 2006), which may have impacted 
results. 
Other methodological issues limit the generalizability of these initial results.  
First, although understandable in the context of a VA-based trial, the PME intervention 
was administered in the second month of a 12-month program, potentially missing many 
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earlier treatment dropouts.  Moreover, post-treatment symptoms were not assessed to test 
for differences in symptom change for the MI versus psychoeducation groups.  
Furthermore, the aim of increasing retention for a 1-year program is not in line with 
evidence-based practice or generalizable to most other treatment settings.  Overall, it is 
also noteworthy that these results are limited in generalizability to male veterans 
engaging in relatively long-term, group treatments.  As such, this work is limited in its 
ability to provide empirical support for MI as an augmentation to CBT treatments for 
PTSD, especially for female trauma survivors or those attending short-term individual, 
trauma-focused PTSD interventions.  However, these studies provide important initial 
support for the feasibility and utility of an MI based intervention as a precursor to 
trauma-focused treatment. 
A separate group of researchers have examined the applicability of the TTM to 
PTSD-positive veterans.  Rooney et al. (2005) measured SOC (categorical)/ RTC 
(continuous) using the URICA, as well as decisional balance an using unpublished 
measures, in a treatment sample of 53 PTSD-positive male veterans.  All participants 
were enrolled in a preparation group (a 2-day program providing psychoeducation 
regarding PTSD, treatment options, and a general introduction to the SOC model) 
followed by 14 weeks of CBT treatment for 2 days per week.  TTM constructs were 
assessed on the first day of the preparation program, 3 weeks into CBT, post-treatment, 
and at 3-month follow-up.  Higher pre-treatment RTC predicted increased endorsement 
of pros of entering therapy and endorsement of the pros of therapy predicted engagement 
in treatment.  Decreasing endorsement of the cons of engaging in therapy predicted 
increase in SOC over time.  The authors note change in SOC across treatment and change 
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in RTC at follow-up, but these changes failed to reach significance in their sample. 
The authors point to the lack of change in SOC/RTC over times as a major 
limitation to the applicability of the TTM model to PTSD.  However, they report an 
extremely low retention rate and acknowledge that low power and few individuals in the 
pre-contemplation stage at the initial assessment may have contributed to the lack of 
findings.  It is also possible that individuals who dropped out may have felt better and 
thus not felt the need to participate further, potentially masking an effect on SOC over 
time.  Moreover, this work did not employ a MI-based intervention specifically targeted 
at changing SOC; thus null findings on this outcome may indicate an insufficient 
intervention.  Overall, this work provides mixed support for the applicability of the TTM 
to a PTSD-positive sample, and raises questions as to the applicability of the TTM model 
to predict changes over time.  However, the lack of expected findings in this study needs 
to be considered in the context of the limitations discussed.   
In a later report using the same sample, the Rooney group (2007) used the 
continuous RTC to predict changes in PTSD outcomes at 3-month follow-up.  Results of 
this study revealed that initial RTC predicted 3-month PTSD symptom severity even 
when controlling for pre-treatment PTSD symptom severity.  Additionally, increases in a 
RTC predicted decreases in PTSD symptoms over time.  These results suggest that a 
client’s initial RTC may affect overall treatment outcomes, and that bolstering RTC with 
MI may improve PTSD symptom outcomes for clients.  This secondary analysis provides 
stronger initial support for the ability of the TTM to predict PTSD treatment outcomes 
but needs replication.   
As is evident from the paucity of studies reviewed, the applicability of the TTM 
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and MI to PTSD has only begun to be examined.  Results to date are limited regarding 
the utility of MI for PTSD but do indicate that MI may help survivors identify areas for 
change, increase their attitudes regarding treatment, and have more consistent therapy 
attendance.  Similarly, results regarding the applicability of the TTM for PTSD are 
mixed, but provide some support for the relevance of TTM constructs in PTSD.  These 
mixed findings produced thus far may be due, in part, to the limitations of the studies 
themselves as well as a general lack of consensus regarding the measurement of MI-
related constructs.  Moreover, the only studies that have utilized MI interventions for 
PTSD have used group-focused MI protocols in VA settings to prepare individuals for 
diffuse group-based PTSD-interventions alongside other treatments and lacked 
assessment of symptom change following these interventions.  Thus, given the current 
state of the research, it is premature to draw conclusions regarding the efficacy of MI for 
PTSD or the generalizability of MI or TTM-related findings to civilian samples.  As such, 
a review of MI in the treatment of other anxiety spectrum disorders is provided to 
examine the ability of MI to address similar concerns in closely related samples. 
Review of the Efficacy of MI for Anxiety Disorders 
Recent years have seen a growth in the application of MI as a precursor to CBT 
for a broader range of psychopathology, including several anxiety disorders (Arkowitz et 
al., 2008).  Initial studies across the anxiety disorders have used MI to attempt to decrease 
dropout, increase treatment engagement and compliance, and reduce ambivalence around 
change prior to CBT.  Several recent studies across the anxiety disorder spectrum have 
supported the use of MI as an effective prelude to traditional CBTs.  In a study of 55 
participants with mixed anxiety disorder diagnoses (45% panic disorder [PD], 31% social 
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phobia, and 24% GAD), three sessions of MI (MI+CBT) were compared to a 
pretreatment WL (WL+CBT) (Westra & Dozois, 2006).  In this study, the individually 
administered MI intervention utilized each of the four principles of MI with a focus on 
resolving ambivalence around changing anxiety problems and around specific treatment 
procedures.  Results revealed that MI+CBT participants reported increased expectancy of 
treatment outcomes and reported greater CBT homework compliance and that a higher 
proportion of MI+CBT participants met criteria as treatment responders than WL+CBT 
clients.  Additionally, there was a trend (p = .08) for lower dropout in the MI group (16% 
for MI versus 37% for WL).  These results suggest that MI may be an effective prelude to 
CBT for anxiety disorders insofar as MI bolstered participants’ engagement in treatment 
as well as treatment credibility. 
A related study of 67 mixed diagnosis anxiety clients expanded upon these results 
by further assessing the relationship between proposed process and change variables 
(Westra, Dozois, & Marcus, 2007).  Analyses revealed that the relationship between 
expectancy for change and anxiety treatment outcomes was mediated by homework 
compliance and initial symptom change in a group of individuals receiving CBT for 
GAD and PD, but not for social phobia.  Specifically, this study found that, for 
individuals with PD and GAD, expectancy for change predicted homework compliance, 
which predicted initial symptom change, which in turn predicted overall treatment 
response, suggesting a pathway of clinically significant change predictors.  The finding 
that initial symptom change predicted overall treatment response is interesting, and 
highlights a possible role of initial change in maintaining motivation for treatment and 
validating self-efficacy for change.  Although this study did not specifically utilize MI, it 
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illuminates potential pathways for increasing therapeutic change that may be addressed 
by MI interventions. 
Positive results have also been observed in a study of 76 participants with GAD 
assigned to MI+CBT or WL+CBT (Westra, Arkowitz, & Dozois, 2009).  MI was again 
individually administered and followed the same manual as the Westra and Dozois 
(2006) study.  In this trial the MI group reported significantly lower worry following pre-
treatment and were more likely to meet criteria as treatment responders following CBT as 
compared to WL+CBT.  Additionally, therapist rated homework compliance was higher 
in the MI group, which partially mediated treatment outcomes.  Moreover, those with low 
internal motivation and those with high worry severity at baseline, both groups at 
increased risk of poorer treatment outcomes, appeared to receive particular benefit from 
the MI+CBT treatment, such that these variables partially moderated the treatment 
response to MI.  This study provides additional support for the utility of MI as a prelude 
to CBT-based anxiety treatments and echoes previous findings that MI increases 
homework compliance and overall treatment outcomes.  Consistent with the different 
therapeutic styles, clients rated therapists as more evocative and less directive and 
described themselves as more active participants in the therapeutic process when CBT 
was proceeded by MI than when it was preceded by WL.  Clients also endorsed a 
symbiotic balance between MI and CBT and expressed that they gained more from CBT 
having prepared in MI (Kertes, Westra, Angus, & Marcus, 2010).   
A final initial pilot trial of MI as a precursor to exposure and response prevention 
(ERP) lends support for the utility of MI as a preparatory strategy for clients with 
obsessive-compulsive disorder (OCD) as well.  Specifically, in a 12 person randomized 
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pilot intervention, participants who received four sessions of a readiness intervention (RI) 
based on MI principles were significantly more likely to enter ERP and showed greater 
treatment gains in ERP than WL participants (Maltby & Tolin, 2005).  The individually 
administered RI intervention was specifically focused on increasing entrance to treatment 
for treatment refusing clients and thus focused on ambivalence around treatment 
procedures as well as symptom change more generally.  Dropout analyses from ERP 
were not possible due to the small sample size.  However, following RI six of seven 
participants entered ERP, 50% of whom dropped out, compared to one of five 
participants who entered and completed ERP following WL.  This result is taken as an 
important gain as all participants had initially refused treatment.  A secondary finding of 
this trial was that SOC as measured by the URICA did not predict entrance into treatment 
within this group.  In fact, the majority of participants were in the contemplation or action 
stages at baseline, despite having recently refused to enter ERP.  It is unknown if the 
continuous RTC measure would have produced similar results.  In this sample, only a 
reduction in the fear of treatment following MI predicted entrance into ERP.  Although 
the RI intervention was focused more specifically on helping clients to begin ERP, some 
findings may generalize to other anxiety disorders.  In particular, the finding that fear of 
treatment was reduced with RI may generalize to other anxiety disorder treatments, 
which inherently ask participants to decrease avoidance of a feared stimuli (e.g., 
discussing a trauma in PTSD treatment).  Moreover, these findings suggests that for 
treatment refusers, and possibly for those with higher levels of fear of treatment in 
general, reduction of fear of treatment may play a larger role in decreasing ambivalence 
than increasing overall RTC. 
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Taken together, the above studies provide initial support for the ability of MI to 
target several important factors within anxiety disordered populations, including 
treatment engagement, treatment expectations, homework compliance, treatment 
retention, client ratings of therapist warmth, and enhancement of overall outcomes when 
paired with CBT for a range of anxiety disorders.  Of note, the studies reviewed within 
the broader anxiety disorders literature employed considerably different methodologies 
when compared to the two studies of MI for PTSD, suggesting that future PTSD studies 
may expand upon current results by employing cleaner study designs.  Additionally, 
results from both the PTSD and other anxiety disorder literatures suggest some 
limitations to traditional assessments of SOC, indicating a need for greater attention to 
measures of the efficacy of MI on preparing client for action stage treatments.  Overall, 
although limited to initial trials, available results for studies of MI as a prelude to CBTs 
for GAD, PD, social phobia, and OCD, show promise for the ability of MI to address 
many of the problematic aspects of current PTSD treatments and encourage future 
research to better explore the applicability of MI to CBTs for PTSD. 
 
E. MI as an Augmentation for CPT 
As reviewed above, MI has successfully been used to target ambivalence, 
decrease attrition, and increase response to treatment across a number of disorders, 
including several closely related to PTSD (Arkowitz & Burke, 2008).  Additionally, 
initial research in the area of PTSD lends support to the utility of MI as a potential 
complement to PTSD treatments (Murphy, Cameron et al., 2004; Murphy et al., 2009).  
Moreover, a review of predictors of differential response to CBTs for PTSD revealed 
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many predictors of non-optimal response to treatment (dropout and non-response) and 
positive treatment response, which warrant increased clinical focus.  Although 
ambivalence has not been examined directly in the PTSD literature, a review of this 
concept in the context of the predictors of differential response in PTSD underscored the 
role of ambivalence in current PTSD dropout and non-response.  Specifically, it was 
discussed that many symptom level predictors of non-optimal response might contribute 
to clients’ ambivalence by producing motivations not to change (e.g., not wanting to 
discuss the trauma, feeling shame about disclosure of certain elements of the event) or 
doubts about their own efficacy for change (e.g., “This therapy will not work for me” or 
“I am too damaged”).  Similarly, process-level predictors of outcomes can be 
conceptualized as behavioral indicators of ambivalence (e.g., inconsistent attendance, 
decreased homework compliance, etc.).  Taken together, these diverse lines of research 
lend support to the notion that MI may be a useful augmentation to address the 
problematic issues of dropout and non-response among otherwise effective CBTs for 
PTSD.  Previous literature examining the use of MI techniques as a compliment to CBT 
has included only group treatment formats and no work to date has examined MI as an 
augmentation to a specific CBT approach for PTSD.  This study seeks to address this gap 
in the literature by examining how MI would fit as an augmentation to CPT for PTSD 
within an individual format, especially in light of the meta-analytic finding that MI is 
more effective in individual format (Lundahl & Burke, 2009).   
Given the equivalent effectiveness results for the major CBTs at present, 
including the results of many head to head trials (Bisson et al., 2007), and the ubiquity in 
issues of dropout and non-response among current CBTs for PTSD (Ehlers et al., 2010), 
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MI could be selected as a compliment for any current CBT.  CPT was selected here based 
on several important factors.  First, CPT is specifically derived to treat PTSD and is 
administered in a standard fashion, unlike many other CBTs which utilize a flexible 
application of techniques in each case (Resick, Monson et al., 2008).  This allows for a 
more detailed assessment of the theoretical and practical alignment of MI and CPT.  
However, as discussed above, CPT is a well-supported CBT for PTSD that represents a 
range of CBT techniques, including cognitive restructuring and a written assault account.  
As such, CPT provides a model for how MI could complement other behavioral and 
cognitively based PTSD treatments.  Finally, CPT is self-described as primarily a 
cognitive therapy (Resick, Monson et al., 2008), which provides unique overlaps with MI 
techniques that may be de-emphasized in exposure therapies (e.g., use of Socratic 
dialogue).  Thus, this section will discuss the specific fit between CPT and MI at both the 
level of the therapeutic techniques employed and in their theoretical approaches to PTSD, 
as well as how this merger may address the predictors of differential treatment responses 
in PTSD.   
At the broadest level, drawing on the TTM’s SOC as an overarching framework, 
MI conceptually precedes CPT as a preparation stage for the action stage of CPT.  Thus, 
an augmentation using MI as a preparation for CPT would allow individuals to develop 
and solidify motivation for change prior to commencing the active change work in 
trauma-focused therapy.  This may be helpful in two ways.  First, work in other areas of 
anxiety research and initial work within PTSD indicates that not all clients begin CBTs 
for anxiety in an action stage (Murphy, 2008; Westra & Dozois, 2008).  Thus, an action-
oriented CBT model may not meet all clients at the appropriate SOC.  As such, 
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preparation with MI might help clients to resolve remaining ambivalence about the 
change itself and increase readiness to move into an action stage treatment like CPT.  
However, bearing in mind the non-linear stages of the SOC, even clients who present for 
treatment in an action stage may still encounter difficulties with ambivalence or decreases 
in RTC throughout the therapy process (Prochaska & Norcross, 2002).  For these 
individuals, MI prior to CPT would still allow time to predict barriers to treatment to 
solidify RTC, which may bolster against later slips in RTC during CPT.  With this 
foundation, once in CPT, clients may be more able to consistently focus on changing 
trauma-related symptoms and processes, as opposed to grappling with potential 
ambivalence during CPT, thus diluting the specific trauma-focus of the work, an element 
thought to be crucial to CPTs success (Resick et al., 2010). 
Given the posited role of ambivalence as an important factor in both dropout and 
non-response, the consistent treatment of ambivalence across these therapies is critical. 
Fortunately, both CPT and MI emphasize understanding and empathetically validating 
ambivalence (Miller & Rollnick, 2002; Resick, Monson et al., 2008).  Yet, MI as an 
augmentation to CPT prior to active trauma-focused treatment adds to the CPT process 
for addressing ambivalence in important ways.  First, as the focus of CPT is on the 
resolution of trauma-related symptoms, CPT necessarily addresses ambivalence once it 
has been identified as a problem in therapy.  Thus, ambivalence is only directly addressed 
once the client’s behaviors are already creating barriers to change.  MI further validates 
and normalizes ambivalence by placing it up front in treatment (Arkowitz et al., 2008).  
This creates the opportunity for clients to explore any existing ambivalence to change or 
to treatment before dropout or treatment interference patterns occur.  This initial focus 
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may also allow clients to more easily address and confront ambivalence with the therapist 
once CPT begins, allowing for a more fluid and consistent focus on trauma-related work.  
This was supported by a recent qualitative study in which clients endorsed a 
complementary role of MI as being a helpful preparation to understand the issues they 
needed to work on in therapy (Kertes et al., 2010).  The general alignment of the 
treatment of ambivalence is critical to the success of merging MI and CPT; however, it is 
also important to consider how specific ambivalence related factors would be treated 
using MI for PTSD.   
Several PTSD symptoms and related clinical features were identified as predictors 
of non-optimal response and may contribute to increased ambivalence.  Augmenting CPT 
with MI prior to treatment would allow clients to begin combating potential symptom-
driven ambivalence prior to trauma-focused work in several ways.  First, during MI, 
clients would be asked to consider if symptoms or patterns related to PTSD are problems 
they would like to change (e.g., clients may want to sleep better, but not want to face 
their traumatic memory) and to consider discrepancies in their current internal 
motivation.  Additionally, clients could identify and label behaviors that represent 
ambivalence around the decision to change problems (e.g., reacting angrily or 
withdrawing).  This opportunity would allow them to explore the costs and benefits to 
changing these patterns prior to engaging in active change work.  Similarly, clients could 
identify and process fears about treatment itself, which was noted as a frequent reason for 
dropout in a clinical survey (Zayfert & Becker, 2000) and the amelioration of which 
predicted entrance into treatment for OCD (Maltby & Tolin, 2005).  Finally, MI would 
allow clients to predict and prepare for the ways in which PTSD-related symptoms might 
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become barriers to treatment (e.g., avoidance of therapy or thoughts that treatment will 
not work for them).  Thus MI addresses potential symptom driven dropout and non-
response in three novel ways: 1) allowing clients to consider if a specific symptom is a 
problem they would like to change, 2) allowing clients to consider why they might not 
want to change certain symptoms and deciding if the task of treatment is worth the 
benefits, and 3) allowing client to consider how these symptoms might become barriers to 
treatment before embarking on the task of symptom-change.  All of these may help 
forestall ambivalence, thus reducing the risk of early treatment termination, as well as the 
dilution of trauma-focused work in CPT and non-response to treatment. 
Let us consider these principles in the context of specific PTSD outcome response 
predictors.  For example, higher PTSD symptom severity, and higher avoidance 
symptoms specifically, predict poorer treatment response, possibly due to the 
contribution of avoidance to ambivalence surrounding symptom change involving facing 
the trauma.  At present CPT addresses the role of avoidance through psychoeducation and 
addresses markers of ambivalence (e.g., homework non-compliance, missed sessions, 
etc.) through collaborative problem solving and use of the therapeutic rationale 
throughout treatment.  However, current rates of dropout and non-response demonstrate 
that these approaches are not sufficient for all trauma survivors (Bradley et al., 2005).  If 
survivors were assisted in considering the pros and cons of avoidance (e.g., avoiding 
emotional pain in the short term while increasing nightmares), the impact of their trauma-
related avoidance (including potential avoidance of therapy), as well as the costs of PTSD 
treatment (i.e., facing their trauma), prior to trauma-focused treatment in a validating 
environment, they could decide if they would like to change this specific behavior and 
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use internal motivation to commit more fully to the task of therapeutic change.  Similar 
processes could be undertaken with any PTSD symptom or related clinical feature (e.g., 
anger, anxiety and worry, substance use, etc.) or the prioritizing of logistic barriers to 
help each individual client process the challenges that they may face in the therapeutic 
process with the support of a therapist who sees their ambivalence as reasonable and 
worthy of consideration prior to the beginning of change work.   
Similarly, several of the symptom-related factors identified as indicators of 
dropout and non-response reflect potential hopeless or self-defeating cognitions regarding 
the therapy itself or clients’ ability to succeed in treatment.  For example, as discussed by 
Bryant et al. (2007), individuals who catastrophize may predict that they will not be able 
to succeed in treatment or meet treatment demands.  Individuals who sense that they have 
been permanently changed or who are experiencing high levels of hopelessness may want 
to change but may also believe that treatment will be unable to work for them.  CPT 
offers many tools that help address these potential ambivalence-producing cognitions.  
First, a discussion of the therapeutic rationale and treatment plan is designed to help the 
client understand the demands of treatment as well as how therapy will be effective.  
Similarly, hope instillation is a large part of any first session of CPT and is designed to 
increase clients’ belief that they can achieve change (Resick et al., 2010).  MI adds 
several additional techniques to address clients’ ambivalent approach to treatment.  First, 
ambivalence fostering symptoms (e.g., hopelessness) and cognitive styles (e.g., sense of 
permanent damage or catastrophizing) can be identified and explored through MI as 
motivations not to change and potential barriers for treatment, and revisited as needed 
using Socratic dialogue during CPT as needed.  Additionally, as the therapist works on 
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developing discrepancy in MI, the discrepancy of clients’ behavior of treatment seeking 
and simultaneous belief that they cannot meet the demands of treatment can be explored.  
Finally, self-defeating, hopeless, and catastrophizing cognitive patterns may be balanced 
by MI’s focus on increasing self-efficacy, which aims to increase clients’ beliefs that they 
can succeed in making desired changes, thus challenging clients’ cycle of hopeless or 
defeated self-cognitions regarding treatment that may produce ambivalence during CBT.  
As such, MI offers several complementary techniques for targeting predictors of non-
optimal PTSD treatment responses.   
Once trauma-focused therapy begins, many elements of the existing CPT theory 
and protocol are also consistent with MI principles.  CPT, like all CBTs, is built upon 
mutual respect and conceptualized as a team approach (Resick & Schnicke, 1992).  This 
approach fits nicely with the client-centered yet directive stance of MI (Miller & 
Rollnick, 2002) in that both therapeutic approaches emphasize the clients’ role as the 
directors of the therapeutic process with the assistance and consultation of the therapist 
who is directive only in ways consistent with helping the clients to realize their own 
therapeutic goals.  At a practice level, MI utilizes clients’ own reasons for change and 
intrinsic motivation to promote RTC.  This approach is consistent with the use of the 
Socratic method, which is critical to CPT’s success, such that the decision to change lies 
in the client’s hands with the clinician acting as a guide and consultant during the 
process.  Similarly, the CPT protocol includes psychoeducation designed to educate 
clients about the potential interference of avoidance along with instructions for clinicians 
to routinely ask clients to anticipate barriers or avoidance to homework compliance and 
to address any ambivalence noted in treatment (Resick et al., 2010).  The resolution of 
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ambivalence during MI would likely lead to decreased ambivalent behaviors during 
treatment; however, careful attention to potential indicators of ambivalence, such as 
inconsistent treatment attendance or homework compliance, could help to continue the 
processing of ambivalence throughout treatment.  If apparent during CPT, these 
behaviors could be discussed using an MI and CPT consistent stance drawing on the 
client’s own motivational decisions and rationale, developed during MI sessions.  Thus 
the MI augmentation of CPT could further complement the specific cognitive strategies 
already used within the CPT model providing enhanced treatment of ambivalence 
throughout the therapy process, with the goal of improving PTSD treatment outcomes for 
survivors.   
 
F. Current Study 
The present study sought to implement MI prior to CPT (MI+CPT) to investigate 
the ability of the MI intervention to influence ambivalence and RTC prior to and during 
trauma-focused treatment and to enhance the efficacy of CPT for decreasing PTSD and 
related psychopathology (i.e., depressive symptoms).  This augmentation involved two 
related components.  First, MI was used as a preparation for CPT, building and 
solidifying motivation to change.  Second, MI skills were utilized throughout the CPT 
protocol to bolster motivation and enhance participant engagement in the treatment 
process.  These interwoven aims were assessed using two strategies.  For each 
hypothesis, the results of the MI intervention were first tested to assess for meaningful 
change within the pilot sample.  Second, the results of participants assigned to MI+CPT 
were compared to a sample of participants in a parallel trial (the Hypnosis Study) 
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conducted simultaneously in the same facility using the same measures, assessors, etc. 
(described in detail below).  There were several important differences between the two 
research projects (also described below).  Finally, the MI study results were located 
within the larger literature throughout the discussion to allow for comparison with the 
larger literature. 
Specific Aims and Hypotheses 
Aim 1.  We first sought to investigate the ability of MI to influence ambivalence 
and RTC prior to CPT.  Given the lack of clarity in the current literature regarding the 
measurement of factors related to the change process, several factors were assessed. 
Hypothesis 1. It was hypothesized that MI would increase RTC in the pilot 
sample.  We specifically anticipated that MI participants would report increases in 
RTC between pre-treatment and following MI prep sessions (i.e., at mid-
treatment).  1a) Comparison RTC data were also available for the comparison 
sample.  It was additionally anticipated that participants in the previous study who 
did not receive MI would evidence fewer changes in RTC between pre-treatment 
and CPT than MI+CPT participants. 
Hypothesis 2. Second, it was hypothesized that MI participants would report an 
increase in the pros of changing and a decrease in the cons of changing following 
MI.  Although there is no universally accepted measure of ambivalence, the pros 
and cons of change capture the decisional balance inherent in wanting and not 
wanting change, and are judged to be the closest marker of ambivalence available. 
Hypothesis 3. Third, it was hypothesized that MI participants would evidence 
increases in CPT treatment expectations and a reduction in fear of treatment 
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following MI. 
Aim 2.  Next, this study sought to investigate the utility of augmenting CPT with 
MI components throughout the CPT protocol.  Specifically, we aimed to investigate the 
utilization of MI during the CPT protocol and impact of MI implementation on RTC 
during the CPT protocol.  
Hypothesis 4. Specific hypotheses were limited given the novel nature of the MI 
augmentation; however, it was anticipated that participants would vary in their 
need for MI supplementation during the CPT process.   
Hypothesis 5. Finally, it was hypothesized that the use of MI components during 
the CPT protocol would result in changes in RTC at the following session, 
specifically that RTC would increase following MI augmentation at the prior 
session.   
Aim 3. The final aim of the current study was assess the tolerability of MI+CPT 
and to test the efficacy of the pilot intervention on conventional trauma-focused treatment 
outcomes.   
Hypothesis 6. It was hypothesized that MI+CPT participants would rate the 
overall therapy experience positively, and that ratings would be comparable to 
CPT without MI (6a).  Similarly, we anticipated that MI+CPT participants would 
endorse MI techniques, both during the initial MI sessions and during CPT, as 
helpful to maintaining their motivation for change. 
Hypothesis 7. It was hypothesized that MI+CPT participants would evidence a 
low dropout rate in the context of the broader PTSD treatment literature.  7a) 
Similarly, it was anticipated that a higher percentage of participants who began 
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MI+CPT would complete CPT than those who began CPT without MI in the 
comparison Hypnosis study.   
Hypothesis 8. It was anticipated that the MI intervention would influence 
treatment engagement as measured by CPT treatment credibility ratings at CPT 
session 1, missed sessions, and homework completion.  8a Consistently, it was 
hypothesized that MI participants would evidence higher engagement than those 
who began CPT without MI (i.e., higher treatment credibility at session 1 of CPT, 
more consistent therapy attendance during CPT, and better compliance with CPT 
homework than individuals who did not receive MI). 
Hypothesis 9. It was further hypothesized that the MI intervention would have 
the additional benefit of positively influencing PTSD and depressive symptoms.  
9a)  It was anticipated that MI+CPT participants would realize greater PTSD and 
depressive symptom changes at follow-up than individuals who received CPT 
without MI. 
  
G. Methods 
Participants 
Eligible participants were adult females who met criteria for a current PTSD 
diagnosis related to a physical and/or sexual assault at least 6 months prior.  There was no 
upper limit on time since assault.  Exclusion criteria for participants included psychosis, 
mental retardation, active suicidality, parasuicidality, or current addiction to drugs or 
alcohol.  In addition, participants could not currently be in an abusive relationship or 
being stalked.  For marital rape or intimate partner violence, the participant must have 
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been out of the relationship for at least 3-months.  Participants could continue the use of 
any psychiatric medications throughout the study.  However, they had to keep their 
medication usage stable for the duration of the study and had to be stabilized on any new 
medication for 1-month prior to the pre-treatment assessment.  Finally, participants could 
have received any therapy in the past, with the exception of CPT, and could be receiving 
concurrent therapy as long as it was not trauma-focused.   
In all, 33 women were assessed for eligibility.  Of these, 10 did not meet study 
criteria (8 PTSD negative, 1 peri-traumatic exposure, and 1 suicidal ideation) and an 
additional 2 participants did not complete the assessment.  Of the 21 women enrolled into 
the trial, 4 met initial study exclusion criteria subsequent to randomization (2 for 
medication instability and 2 for current psychosis).  Thus, the MI intent-to-treat (ITT) 
sample consisted of 17 women who were immediately enrolled into the MI+CPT trial.   
Procedure 
Female survivors of physical and/or sexual assault were recruited for the MI study 
from the greater St. Louis metropolitan area through many of the same mechanisms used 
for recruitment of participants in recent treatment trials.  The primary source of 
participant recruitment was through self-referral to ongoing projects and through our 
clinic.  Referral sources included many metropolitan victim assistance programs, local 
agencies and therapists, as well as fliers posted at grocery stores, laundromats, and on 
college campuses.  Graduate research assistants described the study to potentially eligible 
callers during a clinical intake call.  Female participants, at least 18 years of age, who 
experienced a physical and/or sexual assault as least 6-months prior were screened for 
eligibility.  Interested participants meeting the initial inclusion requirements were 
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scheduled for a pre-treatment assessment.  During the pre-treatment appointment, the 
therapist obtained informed consent, conducted the clinician administered interviews, and 
administered the self-report measures.  There were no adverse events and the study was 
conducted with UMSL Institutional Review Board approval. 
Eligible participants were enrolled directly into MI+CPT (described in detail 
below). The first MI session was scheduled at least 1 week after the pre-treatment 
appointment.  Following the three MI sessions participants completed a brief mid-
treatment diagnostic assessment before beginning CPT.  Participant progress in therapy 
was measured across multiple domains.  PTSD and depressive symptom severity as well 
as RTC and ambivalence were measured at every session.  Additionally, the therapist 
tracked participant attendance and participants completed a homework compliance 
measure at each session.  An independent assessor conducted a post-treatment assessment 
approximately 2-weeks after participants completed treatment and a follow-up 
assessment 3-months after therapy completion using the CAPS and SCID-I as well as 
self-report measures (see Measures section below for details).   
All study assessment and treatment was provided free of charge.  The current trial 
did not advertise any additional participant compensation, above the provision of free 
treatment.  Following the completion of treatment or premature termination, all 
participants were offered $50 for the completion of a final assessment.  It was hoped that 
advertising only free treatment would allow for a more clear assessment of participant 
motivation in the MI trail, would more closely mimic current clinical practice, although 
other issues of secondary gain (e.g., seeking disability compensation) may still have 
existed.  Compensation at the post-treatment assessment was added to increase low 
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response to assessment.   
Comparison Sample 
The MI study employed a comparison sample of participants from a concurrently 
conducted study (Sleep-Directed Hypnosis as a Complement to CPT in Treating PTSD; 
National Center for Complementary and Alternative Medicine 1R21AT00407) at the 
Center for Trauma Recovery (CTR).   Briefly, the Hypnosis study aimed to address sleep 
concerns prior to CPT to increase cognitive functioning and decrease arousal prior to the 
initiation of CPT with the goal of enhancing overall CPT outcomes.  Like the MI study, 
the Hypnosis study included PTSD-positive women seeking treatment related to an 
interpersonal assault.  Women in the Hypnosis study were randomized to either 3 
sessions of sleep-directed Hypnosis Training plus 12-sessions of CPT (Hyp+CPT) or 3 
weeks of Symptom Monitoring plus 12-sessions of CPT (SM+CPT).   
The Hypnosis study drew from 181 women who were assessed for eligibility.  Of 
these, 62 did not meet study criteria and 11 individuals did not complete the assessment.  
In all 108 women were randomized into the Hypnosis study, 16 were removed from 
analysis in the study by design for meeting exclusion criteria subsequent to eligibility.  
Thus, the Hypnosis ITT study sample (N = 92) included 48 SM+CPT participants and 44 
Hyp+CPT participants.  As described in the Results section below, there were no 
demographic or trauma history differences between the MI and Hypnosis ITT samples 
(see Table 1).  Similar to the MI study, there were no adverse events and the study was 
conducted with UMSL Institutional Review Board approval. 
All Hypnosis study inclusion and exclusion criteria were the same as described in 
the MI study sample above, except that participants in the Hypnosis study had to meet 
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criteria at least moderate sleep impairment at pre-treatment and had to be at least 3-
months (not 6-months) post trauma.  The sleep criterion was not retained for the MI study 
sample, but was not anticipated to skew the eligible pool to a large degree.  Sleep 
disturbance is one of the most commonly reported symptoms of PTSD, occurring in the 
vast majority of those diagnosed (Maher, Rego, & Asnis, 2006).  As described in the 
Results section and seen in Table 1, participants in all conditions fell in the clinical range 
of sleep disturbance, but there was a significant difference between conditions on initial 
sleep disturbance such that MI+CPT participants reported lower initial sleep symptom 
severity than SM+CPT or Hyp+CPT participants.  The three conditions were not 
statistically different on total symptom severity of PTSD and depression at pre-treatment.  
Thus, the difference in sleep impairment did not appear to impact the overall severity of 
the sample.  Similarly, the minimum time since trauma was extended to 6 months in the 
MI study, from the 3-month criteria in the Hypnosis study, to allow time for ambivalence 
to manifest.  A total of 8 out of 92 Hypnosis study participants (8.70%) selected an index, 
or worst, traumatic event between 3 and 6 months prior to treatment.  These participants 
were retained in the comparison sample as each of them also endorsed abuse in 
childhood, and thus could have met the 6-month post-trauma criteria of the MI study.  
Moreover, there were no differences between study conditions on trauma history, 
demographics, initial symptom severity, or readiness to change.  Thus, the time since 
index trauma criteria does not appear to have impacted pre-treatment presentation.  
Hypnosis procedures followed a similar timeline to the MI study, with 
assessments completed at pre-treatment, mid-treatment (prior to CPT), post-treatment, 
and 3-month follow-up, in addition to weekly symptom measures.  However, in addition 
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to receiving free therapy services, women in the hypnosis trial were compensated for 
assessments ($50 for pre-treatment, $25 for mid-treatment, $75 for post-treatment, and 
$100 for 3-month follow-up).  
Although this comparison is limited by the non-randomized nature of the MI 
condition and some protocol differences, utilizing this ongoing trial as a potential 
comparison was optimal for several reasons.  First, given the small nature of this pilot 
trial, randomizing the sample into an MI+CPT condition and a within study comparison 
condition would have significantly limited the power of the study and the amount of data 
gathered regarding the implementation of MI.  The proposed non-randomized 
comparison allowed for the closest approximation possible to a randomized control 
condition.  The two studies drew from the same community, using identical recruitment 
methods, and were completed in at the same facility.  Moreover, the MI study employed 
the same therapist, assessors, and the clinical supervisor as in the Hypnosis study.  
Additionally, the ability to compare MI+CPT with two conditions providing both 
symptom monitoring and an alternate therapy prior to CPT provides a stronger 
assessment of the unique effects of MI.  Specifically, both Hypnosis study conditions 
control for repeated assessments and the monitoring of symptoms.  The Hyp+CPT 
condition also controls for weekly therapist contact, rapport, and an active intervention.  
Finally, the MI+CPT sample was compared wherever possible with the larger PTSD 
treatment outcomes literature to locate the MI study outcomes within the broader 
literature. 
Measures 
Interviews. 
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Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995) is a 22-item 
scale with three associated features assessing validity, severity, and improvement.  The 
CAPS contains separate 5-point frequency and intensity rating scales (0-4) for symptoms 
identified with PTSD in the DSM-IV.  The CAPS also has items that rate social and 
occupational functioning, global PTSD symptom severity, and the validity of the 
participant’s responses.  Inter-rater reliability on both frequency and severity ratings is 
reported to be better than .92 for each of the three symptom clusters.  Internal consistency 
was also good for the three subscales using intensity ratings with an alpha of .87 for each 
of the symptom clusters (Weathers et al., 1992).  Convergent validity was high for the 
following measures: Mississippi Scale for PTSD, .91, MMPI-2 PTSD scale, .77 and 
SCID PTSD, .89.  In the current study the CAPS was used to establish a PTSD diagnosis 
and to measure the severity of PTSD symptoms at each assessment time point.  Internal 
consistency in the current study was high (  = .89). 
Structured Clinical Interview for DSM-IV-Patient Version (SCID; First, Spitzer, 
Gibbon, & Williams, 1996) is a diagnostic interview developed based on criteria from the 
DSM-IV.  The SCID was used to assess commonly co-morbid Axis I disorders (Mood 
Disorders, Substance Use Disorders, and panic disorder).  The interview has generally 
yielded moderate reliability coefficients.  For most of the major categories (bipolar 
disorder, major depression, alcohol abuse/dependence), test-retest reliability was 
established with kappas for current and lifetime diagnoses were above .60, with mean 
kappas of .61 for current and .68 for lifetime diagnoses for the combined samples.   
Self-report measures, psychopathology. 
Posttraumatic Stress Diagnostic Scale (PDS; Foa, Cashman, Jaycox, & Perry, 
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1997) is a brief screening and diagnostic instrument designed to assess the presence and 
severity of PTSD based on the 17 DSM-IV criteria (APA, 2000).  It is a clinically 
oriented, four-part, 49-item self-report instrument.  The current study used section three, 
which assesses the 17 symptoms of PTSD.  Items are rated on a 4-point severity scale and 
summed with higher scores indicating more severe symptoms.  The PDS demonstrated 
high internal consistency (alpha = .92) and test-retest reliability (kappa = .74 for PTSD 
diagnosis; kappa = .83 for total PDS score).  In addition, the PDS-derived diagnosis had 
high agreement with the SCID-I (First et al., 1996) and good sensitivity and specificity.  
Internal consistency in the current study was high (  = .80). 
Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) is a widely 
used measure of depressive symptoms.  The BDI-II contains 21-items assessing cognitive 
and behavioral depressive symptoms corresponding to the DSM-IV criteria for major 
depressive disorder.  Items are rated on a 4-point severity scale.  Total scores are obtained 
by summing the items with higher scores indicating more severe symptoms.  Internal 
consistency in the current study was high (  = .90). 
Self-report measures, RTC and ambivalence. 
University of Rhode Island Change Assessment (URICA; McConnaughy et al., 
1983) is a 32-item self-report measure of RTC.  The URICA is a widely used, generic 
assessment of four stages of change (pre-contemplation, contemplation, 
preparation/action, and maintenance).  Items are rated on a 5-point Likert-type scale from 
1 (strongly disagree) to 5 (strongly agree).  The four-factor structure was validated in 
two outpatient samples and each of the subscales had good internal consistency ( ’s = .88 
to .89) (McConnaughy, DiClemente, Prochaska, & Velicer, 1989; McConnaughy et al., 
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1983).  The scale also includes cutoffs to produce a stage of change based on the total 
readiness score, which will be used only for descriptive purposes.  A recently developed, 
trauma specific form (URICA-T; Hunt et al., 2006), which replaces the term “problem” 
with “trauma issues”, has also demonstrated adequate reliability ( ’s = .61 to .80) in an 
initial sample of 42 individuals with comorbid PTSD and substance dependence.  The 
URICA-T total score was associated with study retention in Hunt et al.’s sample.  The 
original URICA has also demonstrated adequate internal consistency in a sample of 53 
PTSD-positive veterans ( ’s = .80 to .88).  The current study utilized the original form of 
the URICA with specific instructions to focus on “trauma symptoms”.  This procedure is 
in line with the majority of previous studies using MI as a precursor to CBT (Maltby & 
Tolin, 2005; Westra et al., 2009; Westra & Dozois, 2006).  Internal consistency for each 
subscale in the current study was high ( ’s = .80 to .91). 
Pain Stages of Change Questionnaire (PSOCQ; Kerns, Rosenberg, Jamison, 
Caudill, & Haythornthwaite, 1997) is a 30-item measure, originally designed to assess 
readiness to begin to manage pain symptoms.  The four-factors (pre-contemplation, 
contemplation, preparation/action, and maintenance) were found to be internally 
consistent ( ’s = .77 to .86) and stable over time (1-2 week test re-test reliability = .74 - 
.88) with good support for discriminant and criterion-related validity.  This measure was 
modified to assess trauma symptoms (MPSOCQ) as a comparison to the URICA, and 
was piloted in the comparison sample.  While not optimal, modifications across patient 
populations have been a consistent practice within the burgeoning MI literature 
(Arkowitz et al., 2008).  Internal consistency for each subscale in the current study was 
high ( ’s = .80 to .86), with the exception of the contemplation subscale (  = .63). 
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Psychotherapy Decisional Balance Scale (PDBS; Bellis, 1994) is a 20-item 
instrument that assesses the pros and cons of engaging in psychological therapy.  It 
demonstrated internal consistency and discriminative validity in the original outpatient 
sample.  Additionally, each factor demonstrated adequate internal consistency in Rooney 
et al.’s (2005) sample of 53 PTSD-positive veterans (  = .87 pros and .90 cons).  Internal 
consistency for each subscale in the current study was acceptable (  = .77, pros and 
cons). 
Therapeutic Outcome Questionnaire (TOQ; Foa et al., 1991) is modified from the 
Expectancies Rating Form (ERF; Borkovec & Nau, 1972), a widely used brief measure 
of treatment expectations and credibility.  The TOQ has previously been used with the 
CPT protocol (Resick, Galovski et al., 2008).  Four items are rated, from 1 (not at all) to 
9 (extremely): How logical does this type of treatment seem to you?  How successful do 
you think this treatment will be in reducing your trauma-related symptoms?  How 
successful do you think this treatment will be in reducing other personal problems?  How 
confident would you be in recommending this treatment to a friend with similar 
problems?  The ERF composite score demonstrated adequate internal consistency (  = 
.73) in an OCD sample (Maltby & Tolin, 2005).  Internal consistency in the current study 
was also adequate (  = .78). 
Fear of therapy.  To the knowledge of the researchers no measure currently exists 
to measure fear of change or fear of therapy.  However, this factor was indicated as an 
important predictor of entrance into therapy in a related study of OCD (Maltby & Tolin, 
2005).  As such, this study employed a single item measure of fear of entrance into 
therapy, identical to that used in the previous trial (assessed using a single item rated 
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from 0, I am not at all afraid to start therapy, to 100, I am so afraid to start therapy that I 
could not stand it). 
Therapist feedback form.  Participants were asked to provide feedback about 
their experiences in treatment at the post-treatment appointment.  This home grown 
measure has been used in several previous CPT trials at CTR (Resick, Galovski et al., 
2008; Resick et al., 2002) and provides quantitative (e.g., Please rate your overall level of 
satisfaction with this therapy) and qualitative information (e.g., What did you like about 
your therapist?) regarding client experiences.  MI+CPT participants were also asked to 
provide feedback about their experience of MI to qualitatively assess the tolerability of 
this additional treatment component. 
Therapy process measures. 
Engagement and Homework Compliance.  Homework compliance was tracked at 
each CPT session in two ways.  First, the therapist tracked both the number of times the 
participant practiced the assigned skills and the number of minutes spent practicing each 
skill, as well as the degree to which out of session work was helpful.  These homegrown 
measures correspond to the assignment given in the preceding session as well as to all 
previous assignments and provide the clinician with a good basis for deriving amount of 
time spent working on therapeutic issues (in accordance with therapy protocol) which can 
then be divided by the number of days since the last session.  Second, the therapist 
completed a measure of client engagement in session as well as perceived client 
homework compliance per specific assignment at each session. 
Attendance.  Session attendance, out of session contact, no showed 
appointments, and cancellations were tracked as part of routine clinical care by the 
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therapist and tallied at the close of each case. 
MI utilization tracking.  The therapist tracked the use of MI techniques 
throughout the MI and CPT protocols to document the specific techniques used, the 
reason for their use, and the perceived participant response to the techniques. 
Treatment Condition 
All participants in this pilot project were assigned to MI+CPT.  Resick et al.’s 
(2010) updated CPT protocol, was utilized following  3-sessions of MI according to 
Westra and Dozios’s (2003) MI protocol.  This MI protocol was designed specifically for 
use in the anxiety disorders.  This project aimed to further refine the treatment manual for 
future use in PTSD positive populations.  Thus, Westra and Dozios’s manual served as a 
basis for the MI augmentation.  The initial 3-session format was kept consistent to allow 
for comparison and ensure the retention of empirically validated treatment elements, 
while simultaneously integrating trauma specific-elements into the MI protocol.  The MI 
techniques developed in the initial sessions were utilized as needed during the CPT 
protocol, thus providing a fluid transition through these two approaches.  Participants 
completed between 9 and 12 sessions of CPT, according to their progress in therapy.  
This practice is in keeping with the larger literature, in which participants who complete 
75% of the treatment protocol, and who are PTSD negative, are considered treatment 
completers (e. g., Blanchard et al., 2003).  Similarly, this practice is supported by recent 
research suggesting the majority of survivors can achieve good endstate functioning prior 
to the completion of a full 12 sessions of CPT (Galovski et al., 2012).  Thus, the present 
study ensured that all participants obtained the full CPT skill set, but allowed participants 
to terminate if they meet good endstate functioning prior to session 12.  (Participants in 
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the Hypnosis study completed the full 12 session protocol, and no participants terminated 
from that trial during the last three sessions).  A description of the augmentation of CPT 
with MI is provided below. 
Cognitive Processing Therapy.  CPT is primarily a cognitive treatment, which 
incorporates elements of cognitive restructuring as well as memory or emotion 
processing.  Like most CBTs, CPT first introduces the client to PTSD and CPT to set the 
stage for a collaborative endeavor and to provide psychoeducation about the therapy 
process.  Two overarching goals are then addressed.  One goal of CPT is to assists the 
client in processing the emotion-laden traumatic memory.  This goal is accomplished by 
resolving conflicts between memories of the event that have been avoided and fully 
integrating them with pre-existing schemas.  Specifically, clients are asked to write, 
think, and talk about the worst traumatic event they have experienced.  In the memory 
processing component participants are encouraged to activate their memory of the event 
and to experience their emotions.  The other focus of treatment is on the integration of the 
meaning of the event into the client’s larger worldview.  Toward this end, clients are 
assisted in differentiating accurate interpretations from faulty cognitions or “stuck points” 
by writing about the impact of the assault on their beliefs as well as using ABC sheets to 
learn the connection between events, thoughts, and feelings.  Clients are then taught skills 
to assist them in challenging stuck points and generating accurate alternate thoughts.   
The initial focus of the cognitive work surrounds specific stuck points about the 
assault itself (e.g., "It must have been my fault" or "Maybe it wasn't really a rape").  Once 
these assimilated cognitions are resolved, over-accommodated beliefs about other areas 
of functioning are addressed with a focus on the five areas of functioning identified by 
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McCann, Sakheim, and Abrahamson (1988) that are frequently affected by victimization: 
safety, trust, power/control, esteem, and intimacy.  Each of these areas can be divided 
into beliefs regarding oneself and beliefs regarding others.  CPT then concludes by asking 
the client to re-assess the impact the event has had on their worldview with a focus on 
identifying resolved stuck points and engaging clients in relapse prevention. 
Motivational Interviewing Augmentation.  Westra and Dozios’s (2003) protocol is 
a supplement to Miller and Rollnick’s (2002) seminal work, and retains their flexible 
format for change based on the knowledge that individuals enter the change process with 
varying degrees of readiness.  Westra and Dozios integrate this flexible approach into a 
two phase individualizable protocol that retains all of the empirically supported elements 
of MI.  Clients are first introduced to the concepts of ambivalence and the stages of 
change model with the dual goals of normalizing ambivalence and providing an 
understandable treatment rational. Next, the therapist utilizes the MI principles according 
to the client’s level of readiness.  Specifically, in phase 1, the therapist assists the client in 
exploring and resolving ambivalence around change.  This is done flexibly depending on 
the client’s level of change versus sustain talk, with the goal of building discrepancy to 
achieve a resolution to change.  It is in phase 1 that the therapist could, depending on the 
client’s RTC, assist the client in elaborating upon the problems they have and deciding if 
they would like to change them.  In phase 2, the focus of the work shifts to preparing for 
change and building self-efficacy.  This second phase of treatment consists of deciding 
how to bring about desired changes (e.g., “Is therapy worthwhile?”), anticipating 
roadblocks to change, and building positive self-statement about one’s ability to change.  
The session by session augmentation is outlined below.   
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Session Traditional CPT MI Augmentation 
MI 1* n/a 
(Very brief summary of 
trauma-focused treatment 
provided; Acknowledge 
trauma while keeping MI 
focus) 
Psychoeducation regarding MI and 
ambivalence.  Identify problems in life 
potentially contributing to distress.  Discuss 
areas that participant may not have considered.  
Dialogue is consistent with traditional MI and 
is not trauma specific in these first three 
sessions. 
MI 2* n/a 
(Discuss problems in terms 
of where clients are 
“stuck”) 
Continue to weigh costs and benefits of 
problems.  Consider five core belief systems 
(CPT 8-12) and related problems.  Focus on 
developing discrepancy or building self-
efficacy for change based on client’s stage of 
change. 
MI 3* n/a 
(Begin to introduce meta-
cognition) 
Continue discussion of meaningfulness of 
abandoning problems for therapeutic 
movement in the direction of change.  Increase 
awareness of discrepancies thus laying 
groundwork for preparedness for trauma-
focused therapy.  Continue building self-
efficacy and consider barriers to change. 
CPT 1 Psychoeducation:  
PTSD & avoidance, 
cognitive theory & 
application in treating 
PTSD.  Education regarding 
identification of “stuck 
points”.  Assign Impact 
Statement. 
Integrate identified “problems” into session 1 
of CPT and acknowledge their role specifically 
in the development and maintenance of PTSD.  
Begin to label as PTSD avoidance.  Identify 
trauma-specific cognitions and introduce as 
CPT “stuck points”.  Ask individual to consider 
identified problems in writing the Impact 
Statement for the following session. 
CPT 2 Impact Statement.  Early 
identification of stuck 
points and gentle Socratic 
questioning.  Relationship 
between thoughts & 
emotions. 
Assign ABC sheets 
Rely on problem list developed in MI sessions 
to continue to trace and explore the 
meaningfulness of the traumatic event and 
identify any stuck points maintaining PTSD.  
Continue to assess and monitor RTC and rely 
on MI skills developed in early MI sessions to 
increase motivation to continue with therapy if 
needed. 
CPT 3 ABC sheets: continue to 
identify stuck points.  
Challenge with Socratic 
Dialogue.   
Assign trauma narrative. 
Continued exploration of identified problems.  
Continued assessment of RTC and reliance on 
MI techniques if readiness falters.  MI dialogue 
used to discuss any ambivalence around writing 
of trauma narrative. 
CPT 4 Read trauma narrative aloud 
to therapist.  Process natural 
Specifically identify any stuck points related to 
difficulties with out-of-therapy practice 
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emotion.  Identify and 
challenge stuck points with 
Socratic questions.  Re-
assign narrative. 
assignments (i.e.  If I engage in therapy, I will 
become overwhelmed).  Integrate MI 
techniques with Socratic dialogue to address 
stuck points and discuss costs and benefits of 
PTSD positive status quo versus change. 
CPT 5 Reread narrative, identify 
stuck points.  Introduce 
challenging questions.  
Assign challenging 
questions practice. 
Continue to utilize MI techniques to increase 
motivation if necessary.  In the case of 
motivated client, begin to revisit original 
problem list.  Use as a resource to tailor 
treatment to problem list and continue to 
increase meaningfulness of change to 
individual participant.   
CPT 6 Review challenging 
questions.  Introduce faulty 
thinking patterns.  Therapy 
shifts to more current stuck 
points. 
Continue to monitor RTC, utilizing MI 
techniques if motivation is lacking.  May rely 
on problem list to hone and tailor therapy 
(identification of stuck points, etc.) to 
individual if necessary. 
CPT 7 Review faulty thinking 
patterns.  Introduce 
challenging beliefs 
worksheets (cbw’s) and first 
of five modules. 
Use faulty thinking patterns to encourage the 
participant to generalize the skills to more 
current patterns of thought.  MI skills can be 
used to increase motivation towards meaningful 
change in participants’ daily life. 
CPT 8-
12 
Review modules and related 
cbw’s.  Specific 
assignments apply in last 
two sessions.  Rewrite the 
Impact Statement for final 
session. 
Additive benefit of MI in these final sessions 
provides the participant the opportunity to 
revisit the specific problems identified in MI 
session 2 within each of these 5 core belief 
systems and in final Impact Statement.  MI 
techniques can be used to encourage continued 
utilization of the learned skills in relapse 
prevention and to predict barriers to change/ 
maintenance. 
* This session structure were tailored to the specific client’s readiness with these general 
elements included. 
 
Therapists, Assessors, and Reliability and Adherence Ratings. 
An advanced female CPT clinician administered all therapy. The therapist was 
also a primary clinician on the comparison trial.  She completed training in MI (i.e., MI 
workshops and the use of online and video training materials) and obtained weekly 
supervision for adherence to the specified protocol.  Supervision was provided by Tara 
Galovski, Ph.D., a national CPT expert with training in MI.  Independent assessors were 
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graduate students in clinical psychology who also served as assessors on the comparison 
Hypnosis trial.  Consistent with recent pilot protocols, diagnostic inter-rater reliability of 
assessing clinicians and therapist adherence and competence in CPT was drawn from 
ongoing protocols (Constantino et al., 2008).  This financially advantageous design 
provides methodological integrity by assessing the reliability and adherence/competence 
of study clinicians for the study measures and protocol based on concurrent assessment 
and therapy, without requiring funding for these reliability measures from the pilot study.   
Inter-rater reliability was conducted for a random sample of 24 CAPS 
assessments in the Hypsnosis study.  Reliability among coders was high for the CAPS 
diagnosis, cluster scores, and total scores:  (current diagnosis) = 1.00; r = .956 (total 
score), .923 (cluster B), .920 (cluster C), .897 (cluster D).  Expert CPT clinicians not 
otherwise affiliated with the Hypnosis study conducted adherence and competence 
ratings for therapy sessions.  Individual session elements are rated for presence or 
absence and for quality of present elements ranging from 1 (not satisfactory) to 7 
(excellent), with a 4 (satisfactory) midpoint.  Raters coded a total of 61 sessions (8.6% of 
the total 710 sessions conducted, including removed participants).  Additionally, a second 
independent rater coded 14 (or 23%) of these sessions to ensure reliability among 
independent raters.  Inter-rater agreement across sessions was acceptable on both the 
presence of session elements (  = .65) and the rating of session elements (r = .46).  
Using a single coding from each session, 96.78% of the unique session elements were 
judged to be present and 87.71% of present items were judged satisfactory or higher.  The 
average rating of present elements across therapists was 4.51.  Regarding essential but 
not unique items (e.g., warmth, efficient structuring of session time, etc.), 93.8% of non-
 MI to Augment CPT   58 
 
unique elements were judged to be present with 92.56% of present elements judged as 
satisfactory or higher, with an average rating of 4.64.   
Analytic Plan 
Analyses were limited by the sample size in this pilot study.  However, these 
analyses were consistent with several recent pilot trials (Constantino et al., 2008; Tuerk, 
Yoder, Ruggiero, Gros, & Acierno, 2010).  A priori power analyses are noted throughout 
the analysis section, and have been computed using G-Power (Faul, Erdfelder, Lang, & 
Buchner, 2007) unless otherwise noted.  Additionally, achieved power is documented 
throughout the results section to locate this study limitation more accurately.  Per the G-
power user guide, post-hoc power estimates are also based on hypothesized effect sizes 
(medium effect size of Cohen’s f = .25 or  = .30, unless otherwise noted), not observed 
effect sizes, and observed correlations between measures for repeated measures statistics.  
Current sample effect size estimates are provided for each analysis in the results to more 
accurately represent the clinical significance of any changes observed.  The use of effect 
sizes is in line with recent pilot trials and is thought to be a better estimate of change in 
limited samples (Constantino et al., 2008).  Given the small sample, missing data was 
treated carefully in the present study.  First, every effort was made to obtain post-
treatment data from all participants in the MI study, including the addition of $50 
compensation for a final assessment, regardless of treatment completion status.  
However, post-treatment data collection rates were still lower than anticipated.  In cases 
where follow-up data could not be obtained, missing data were treated conservatively 
using a last observation carried forward (LOCF) method from the last available data 
point.   
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In order to provide a comparison for the pilot results, the Hypnosis study was 
used as a comparison where possible.  Prior to comparison testing, pre-treatment 
differences were assessed across the MI study and Hyp/SM+CPT conditions.  Only one 
pre-treatment difference reached statistical significance (initial CAPS sleep severity, p < 
.0001), such that MI +CPT participants reported a lower severity of sleep concerns than 
Hyp/SM+CPT participants.  Additionally, some trends emerged on demographic 
differences between conditions (years of education, p = .053; marital status, p = .075; 
race, p = .093).  Pre-treatment difference variables were assessed for associations with 
dependent variables for each hypothesis to insure that they did not have undue influence 
on study outcomes.  Specifically significant associations of initial sleep disturbance 
severity, years of education, martial status, and race with dependent variables are noted 
by analysis.  Pre-treatment differences were controlled when significantly associated with 
the DV.  Specific analyses are outlined per study hypothesis. 
 
Aim 1.  Assess the ability of MI to influence ambivalence and RTC prior to CPT.   
Hypothesis 1. First, repeated measures MANOVAs of the MI sample were used 
to test the hypothesis that MI participants would evidence increases in RTC (using 
the URICA and MPSOCQ) during MI.  A sample of 10, or 20 observations, was 
estimated to provide 80% power for a large effect size (Cohen’s f = .50).  1a) Data 
were available for comparison with change in RTC over the Hypnosis preparatory 
sessions  Repeated measures MANOVAs were used to test the hypotheses that MI 
would differentially increase RTC prior to CPT when compared to those receiving 
a sleep-directed intervention (Hyp+CPT) or completing symptom monitoring 
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(SM+CPT) prior to CPT.  A combined sample of 50 was estimated to provide 
80% power to detect a medium to large effect size (Cohen’s f  = .35). 
Hypothesis 2. A repeated measures MANOVA of the MI sample was also used to 
test the hypothesis that the pros of therapy will increase and cons of therapy 
would decrease over the course of the MI preparation sessions.  A sample of 10, 
or 20 observations, was estimated to provide 80% power for a large effect size 
(Cohen’s f = .50).   
Hypothesis 3. Repeated measures MANOVA of the MI sample was used to test 
the hypothesis that MI participants would evidence increases in CPT treatment 
expectations during MI and decreases in fear of therapy.  A sample of 10, or 20 
observations, was estimated to provide 80% power for a large effect size (Cohen’s 
f = .50). 
Aim 2.  Investigate the utility of augmenting CPT with MI components 
throughout the CPT protocol.  It was anticipated that participants would display a range 
in their need for MI augmentation during the CPT protocol and that MI would effectively 
address fluctuations in readiness during CPT. 
Hypothesis 4. We anticipated that participants would display a range of need for 
MI techniques during the CPT protocol.  Descriptive statistics were calculated to 
demonstrate the use of MI during the course of CPT, including the sessions at 
which MI was utilized, participant RTC at each CPT session, duration of the MI 
intervention within the CPT session, and the reasons for MI skill usage. 
Hypothesis 5. It was anticipated that the use of an MI intervention during a given 
CPT session would produce an increase in RTC by the next CPT session (i.e., MI 
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would affect readiness when employed during CPT).  Thus, it was hypothesized 
that participants would demonstrate change in RTC (URICA) following CPT 
sessions that employed MI components.  Power analyses were limited as the 
number of CPT sessions utilizing MI was unknown.  A sample of 25 sessions was 
estimated to provide 80% power for a medium effect size (Cohen’s f = .29). 
Aim 3.  Assess the tolerability of MI+CPT and test the efficacy of the MI 
intervention to decrease dropout and increase engagement and treatment outcomes.  
Hypothesis 6. MI study participant therapy rating scores were assessed 
descriptively to ensure a high level of satisfaction with the overall MI+CPT 
intervention.  MANOVA was then used to assess differences between MI+CPT 
participants and comparison groups on ratings of therapy satisfaction (6a).  Power 
analysis for a between groups ANOVA with a sample of 50 participants would 
provide 80% power to detect a large difference between groups (Cohen’s f 2 = 
.16).  Finally, MI study participant feedback regarding the utility of MI 
augmentation was assessed descriptively and compared to written feedback to 
ensure high participant satisfaction with treatment. 
Hypothesis 7. Regarding overall treatment outcomes, the dropout rate of the pilot 
MI study was assessed arithmetically.  7a) Then, chi-square analysis was used to 
test the hypothesis that a higher percentage of participants who began MI+CPT 
would complete therapy than those who began CPT without MI (Hyp+CPT and 
SM+CPT).  Chi square analysis allows for comparisons between unequal sample 
sizes.  The current sample was estimated to provide relatively low power 
(approximately 40%), based on estimated proportions for dropout of 10% 
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(MI+CPT) and 25% (Hyp+CPT and SM+CPT) 
(http://statpages.org/proppowr.html). 
Hypothesis 8. Participant treatment engagement was assessed arithmetically 
within the MI sample for treatment credibility, missed sessions, and homework 
completion.  8a) A MANOVA was then used to test the hypothesis that MI 
participants would demonstrate more treatment engagement than Hypnosis 
participants (i.e., higher treatment credibility at session 1 of CPT, more consistent 
therapy attendance during CPT, and better compliance with CPT homework).  A 
sample of 50 participants was estimated to provide 80% power to detect a large 
difference between groups (Cohen’s f 2 = .15). 
Hypothesis 9. Finally, a repeated measures MANOVA was used to test change 
on primary symptom measures (CAPS, PDS, and BDI-II) for MI+CPT 
participants.  Given the noted challenges in obtaining post-treatment data, 
comparisons were limited to two time points (pre-treatment to follow-up), which 
decreased the reliance on LOCF and most accurately represented the present data.  
Moreover, numerous studies have observed consistent patterns of change 
following trauma-focused treatment, such that participants demonstrate significant 
change across treatment with maintenance of gains at follow-up (e.g., Galovski et 
al., 2012; Resick et al., 2002).  Thus, comparison of change from pre-treatment to 
follow-up allowed for the testing of the initial hypothesis within the limitations of 
the present data.  Non-response rates (PTSD positive status at follow-up) were 
also calculated for the MI+CPT sample.  9a) Next, repeated measures MANOVAs 
were used to test the related hypothesis that MI treatment completers would 
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experience greater gains on primary symptom measures than individuals who 
completed CPT without MI.  Power analysis for a between groups MANOVA 
with 3 groups and 2 repetitions indicated that 50 participants would provide 
approximately 80% power assuming a medium-range effect size (Cohen’s f = .26) 
and a .20 correlation among measures (based on across time point correlations 
among outcome variables in the comparison sample of .10 for the CAPS and BDI-
II for the .15).   
 
H. Results 
Study Sample 
As noted above, the MI study ITT sample consisted of 17 women who were 
immediately enrolled into the MI+CPT condition.  Demographic, trauma history, and 
initial symptom severity and RTC measures are presented below.  The comparison 
Hypnosis ITT study sample (N = 92) included 48 Symptom Monitoring plus CPT 
(SM+CPT) participants and 44 sleep-directed Hypnosis Training plus CPT (Hyp+CPT) 
participants.  MI and Hypnosis study sample comparisons are also described below and 
can be seen in Table 1. 
Demographics.  MI ITT participants ranged in age from 20 to 58 (M = 34.47, SD 
= 11.78).  The group described themselves as predominantly White (76.47%), with Black 
(11.76%), Asian (5.88%), and other (5.88%) races accounting for approximately a quarter 
of the sample.  A total of 11.76% described themselves as Hispanic.  Marital status was 
approximately evenly divided across single (35.29%), married or living with someone 
(35.29%), and separated or divorced (29.41%) status.  The majority reported at least 
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some post-high-school education (94.11%) and an annual household income of $20,000 
or less (64.71%).  No demographic differences emerged when MI+CPT participants were 
compared to the two Hypnosis study conditions (SM+CPT and Hyp+CPT; see Table 1).  
Although between group demographic differences did not reach significance, some trends 
emerged.  Specifically, years of education was marginally significant (p = .053).  Post-
hoc Fisher’s LSD analysis revealed that Hyp+CPT participants reported significantly 
fewer years of education than SM+CPT participants (p = .032) and non-significantly 
fewer years of education than MI+CPT participants (p = .063). Additionally, SM+CPT 
participants were non-significantly more likely to be single than MI+CPT and Hyp+CPT 
participants (p = .075) and the MI group had notably fewer non-White participants than 
the Hyp+CPT and SM+CPT conditions (p = .093). 
Trauma history.  As can be seen in Table 1, MI ITT participants reported a 
complex trauma history.  Participants identified a worst event (or “index event”) for the 
assessment of PTSD and initial treatment focus.  Index events in the MI ITT sample were 
52.94% child sexual abuse, 11.76% child physical abuse, 29.41% adult sexual assault, 
and 5.88% adult physical assault.  Time since the index event ranged from 11 months to 
54.19 years.  No trauma type differences emerged between the MI and Hypnosis samples 
on type of time since trauma, index event, or lifetime trauma history in the total sample. 
Initial symptom and readiness ratings.  Participants across MI and Hypnosis 
study conditions reported similar pre-treatment symptom severity on the CAPS, PDS, and 
BDI-II. Participants across conditions also endorsed similar pre-treatment levels on 
measures of RTC (URICA and MPSOCQ).  Participants were predominately in the 
contemplation and preparation/action stages of change based on the URICA, with only 
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one participant per condition endorsing a pre-contemplation stage of change.  As can be 
seen in Table 1, there was a single significant difference between conditions on initial 
sleep disturbance.  Post-hoc analyses using Fisher’s LSD revealed that, though still in the 
clinical range, MI+CPT participants reported significantly less sleep disturbance than 
either SM+CPT or Hyp+CPT participants.  As noted above, significant and near 
significant differences were assessed for associations with DVs in all models and 
covaried when significant.   
Aim 1  
A primary aim of this study was to investigate the ability of MI to influence 
ambivalence and RTC prior to CPT.  No participants dropped out during MI; however, 
given the higher than expected dropout rate during CPT (discussed below), follow-up 
analyses were also conducted per hypothesis to investigate potential interactions between 
treatment dropout status and change on these measures. 
Hypothesis 1.  Repeated measures MANOVAs were used to test the hypotheses 
that MI would increase RTC (i.e., decrease pre-contemplation and contemplation 
subscales and increase the preparation/action stage subscale) prior to CPT.  This was first 
tested in the MI study sample.  MANOVA results using the URICA subscales revealed a 
marginally significant effect of time which was associated with a large portion of the 
variance in change, F (3, 14) = 3.48, p = .053, 
2
p = .41, Achieved power = .48.  
Univariate analyses found non-significant results across tested subscales associated with 
small portions of the variance in change: Pre-contemplation F (1, 16) = .06, p = .809, 
2
p 
= .00, Achieved power = .48; Contemplation F (1, 16) = 2.89, p = .109, 
2
p = .15, 
Achieved power = .48; Preparation/action F (1, 16) = .32, p = .580, 
2
p = .02, Achieved 
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power = .46.  Thus, it appears MI study participants demonstrated a large, marginally 
significant (p = .053) change in RTC across the MI sessions, which was likely driven by 
the overall pattern of multivariate change as no specific RTC subscales reached 
significance.  Figure 1 displays the overall RTC score for MI study participants across the 
MI sessions for each MI participant by treatment completer status.  
MANOVA results did not reveal a significant effect of time in the MI ITT sample 
on the MPSOCQ, F (3, 14) = 1.15, p = .362, 
2
p = .20, Achieved power = .33.  And 
univariate analyses revealed non-significant results across tested subscales associated 
with small portions of the variance in change: Pre-contemplation F (1, 16) = .63, p = 
.439, 
2
p = .04, Achieved power = .41; Contemplation F (1, 16) = 2.93, p = .106, 
2
p = 
.16, Achieved power = .36; Preparation/action F (1, 16) = .35, p = .564, 
2
p = .02, 
Achieved power = .29. Completer results were nearly identical to ITT results for both 
RTC measures, as only one participant did not complete the MI sessions.  Thus, although 
non-significant, all changes were in the expected direction, with the exception of an 
increase in contemplation as measured by the MPSOCQ (see Table 2).  Results indicate 
that MI had a significant effect on RTC as measured by the URICA, but not the pilot 
measure MPSOCQ, in the MI study sample. 
1a) Repeated measures MANOVAs were also used to compare RTC changes in 
the MI and Hypnosis study samples.  Data were available for a subset of the ITT 
comparison sample (SM+CPT n = 28 and Hyp+CPT n = 23) in addition to the ITT 
MI+CPT sample (N = 17). MANCOVA results (including pre-treatment difference 
variables) demonstrated significant change over the pre- to mid-treatment period, F (3, 
60) = 5.95, p = .003, 
2
p = .21, Achieved power = .95, and the interaction effect of 
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time*treatment condition was marginally significant F (6, 120) = 2.13, p = .055, 
2
p = 
.10, Achieved power = .43.  Univariate results revealed significant effects of time on 
contemplation and preparation/action subscales (p = .001), with a trend on pre-
contemplation (p = .098).  No significant time*treatment condition univariate interactions 
emerged, again suggesting that the pattern of results (and not specific subscale changes) 
were different across conditions.  The pattern of results in the completer sample was 
similar and is presented in Table 2.  Post-hoc analyses were precluded by the use of 
MANCOVA; however, the raw means in Table 2 and estimated marginal means 
displayed in Figure 2 show change in expected directions across conditions with unique 
patterns of change across subscales in the three groups. 
Multivariate results using the MPSOCQ in the ITT sample also demonstrated a 
significant effect of time, F (3, 63) = 3.97, p = .012, 
2
p = .16, Achieved power = .96, and 
a non-significant interaction effect of study condition, F (6, 126) = .66, p = .682, 
2
p = 
.03, Achieved power = .43.  However, the effect of time did not remained significant 
when controlling for pre-treatment difference variables using MANCOVA, F (3, 60) = 
.98, p = .402, 
2
p = .05, Achieved power = .96.  Nor was the interaction of 
time*condition significant in the ITT MANCOVA, F (6, 120) = .55, p = .772, 
2
p = .03, 
Achieved power = .43.  Univarite results indicated a significant main effect of study 
condition on the action subscale of the MPSOCQ, but no time or time interaction effects 
were univariately significant in the final model.  This pattern of results held in the 
treatment completer model (see Table 2).  Figure 2 displays the estimated marginal 
means at pre- and mid-treatment for the three study conditions when including the pre-
treatment difference covariates in the prep-treatment completer samples.  Dropout status 
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was assessed for impact and was not significant in either the URICA or MPSOCQ 
models for main or interaction effects, Fs (3, 47) = .41 to 1.26, ps = .299 to .745.  In sum, 
results of the MI pilot and Hypnosis comparison analyses revealed a pattern of change 
over the pre- to mid-treatment period on the URICA, with possible unique change in the 
MI condition.  The MPSOCQ did not demonstrate significant change in the pilot or 
comparison analyses. 
Note: The remaining hypotheses were tested within the MI study sample only, as 
Hypnosis participant data were not available for these measures. 
Hypothesis 2.  Repeated measures MANOVA of the MI sample were used to test 
the hypotheses that the pros of therapy would increase and cons of therapy would 
decrease over the course of the MI preparation sessions (from pre- to mid-treatment).  No 
significant differences were observed in change over time on pros or cons of therapy, F 
(1, 13) = .26, p = .778, 
2
p = .04, Achieved power = .53, and there were no differences in 
change on these measures by treatment status (i.e., CPT dropout versus CPT completer), 
F (1, 13) = .22, p = .804, 
2
p = .03.  Thus, dropout status did not appear to interact with 
potential effects of MI on change in pros and cons of change over the course of MI. 
Hypothesis 3.  Views of CPT and fear of beginning CPT also did not show 
significantly multivariate change over the course of the three MI prep sessions, F (5, 10) 
= 1.22, p = .368, 
2
p = .38, Achieved power = .49.  However, it is noteworthy that power 
was limited and time accounted for 38% of the variance in change in treatment 
expectations and fear of treatment.  Univariate results revealed small to moderate 
associations between time and change in views and fear of treatment (
2
p = .06 to .13).   
Moreover, there was large, but non-significant interaction effect between time and 
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treatment completer status, F (5, 9) = 2.17, p = .147, 
2
p = .55.  Specifically, univariate 
results revealed that those who went on to complete CPT rated CPT as seeming more 
logical after MI (at mid-treatment), whereas those who went on to dropout rated it as 
seeming less logical than at the first MI session, F (1, 13) = 8.39, p = .013, 
2
p = .39.  
Similarly, those who completed treatment evidenced a non-significant decrease in fear 
over the MI sessions (see Figure 3).  These findings indicate that participants may have 
responded differently to the MI intervention, such that those who went on to complete 
treatment increased their confidence in CPT following MI.  These results are highly 
tentative given the small sample size and non-statistically significant multivariate results.   
Aim 2 
A secondary aim of this study was to investigate the utility of augmenting CPT 
with MI components throughout the CPT protocol.   
Hypothesis 4.  As anticipated, participants displayed a range of need for MI 
techniques during the CPT protocol.  MI interventions were implemented when 
participants verbalized or demonstrated ambivalence (e.g., avoidance of therapy or home 
practice assignments).  Use of MI style during CPT reflected a balance of the MI 
components: empathizing with and normalizing ambivalence, rolling with resistance, 
developing discrepancy, and supporting self-efficacy.  For participants who completed at 
least 9 CPT sessions, MI elements were employed in an average of 2.40 sessions (SD = 
1.90, Median = 2), with a wide variety among cases regarding frequency of MI usage 
within CPT (range = 0 to 6).  There was also a broad range in timing of MI integration, 
with MI being employed across almost the full span of CPT sessions (1 to 10) across 
cases.  However, MI was most often employed at session 4 -- the session following the 
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assignment of the trauma account.  MI was typically employed briefly in MI sessions 
where it was utilized (~5 minutes or less), but in 6 instances, MI was used as a more 
central intervention to address ambivalence during the course of a CPT session.   
Although RTC measures were not utilized to determine use of MI in session, 
MANOVA was used to assess self-reported RTC at sessions where MI was and was not 
employed.  Multivariate tests were not significant, F (8, 125) = 1.61, p = .129, 
2
p = .09, 
Achieved power = .99.  However, univariate results revealed that during CPT sessions 
where MI was employed, participants reported significantly higher contemplation on the 
SOC, F (1, 133) = 4.81, p = .030, 
2
p = .04, Achieved power = .99, and marginally 
significantly higher pre-contemplation on the URICA, F (1, 133) = 3.54, p = .062, 
2
p = 
.03, Achieved power = .99, than at sessions where MI was not utilized.   
Hypothesis 5.  A repeated measures MANOVA was used to test the hypothesis 
that participants would demonstrate increases in RTC following the use of MI 
interventions during CPT sessions.  MANOVA did not find significant change on RTC 
subscales, as measured by the URICA, immediately following sessions when MI was 
implemented, F (12, 82) = .88, p  = .570, 
2
p = .11, Achieved power = .99.  Said another 
way, there was no immediate change in RTC observed between the CPT session in which 
MI was used and RTC at the next CPT session.  Figure 4 displays the session by session 
change in URICA RTC subscales for the four highest users of MI during CPT.  Visual 
inspection shows change in RTC subscales following MI interventions to varying degrees 
for each participant.   
Aim 3 
The final aim of the current study was to test the tolerability of MI+CPT and the 
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efficacy of the MI intervention to decrease dropout and enhance treatment engagement 
and primary symptom outcomes. 
Hypothesis 6.  The tolerability of the MI intervention and participant ratings of 
the overall MI+CPT intervention were assessed in multiple ways.  First, we reviewed MI 
study participants’ satisfaction ratings with the overall therapy (MI+CPT).  MI study ITT 
participants reported high satisfaction with the study therapist (M = 9.38 of 10, SD = .99) 
and moderate to high satisfaction with the therapy (M = 7.58 of 10, SD = 2.40).  6a) 
Overall therapy satisfaction ratings were also compared to Hypnosis study participants’ 
ratings of treatment.  As anticipated, there were no statistically significant differences on 
ratings of satisfaction with therapist, treatment, or study condition by therapy condition 
when MI+CPT ITT participants were compared to SM/Hyp+CPT ITT participants, F (8, 
132) = 1.32, p = .241, 
2
p = .07, Achieved power = .99.  Of note, there was a main effect 
of dropout status across conditions, such that dropouts were less satisfied with treatment 
than completers, F (4, 63) = 2.77, p = .035, 
2
p = .15, Achieved power = .99.  Univariate 
analyses indicated that dropout participants across conditions were significantly less 
satisfied with treatment, F (1, 71) = 10.67, p = .002, 
2
p = .14, Achieved power = .73, but 
not with their therapist, F (1, 71) = 1.11, p = .296, 
2
p = .02, Achieved power = .73, than 
completers.  In all, satisfaction with treatment, therapist, and condition was high in the 
MI pilot study and was similar across treatment studies, indicating that MI+CPT was 
similarly well tolerated. 
Next, MI participant feedback regarding the utility of MI augmentation was 
assessed based on an anonymous self-report measure and written feedback administered 
at follow-up assessments.  Participants endorsed mixed, though largely positive, reactions 
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to the initial prep sessions.  Those who completed treatment reported that they found the 
prep sessions to be “very” logical (M = 8.17 of 9, SD = .98) and “very” helpful (M = 8.83 
of 9, SD = .41).  Only two participants who terminated treatment completed follow up 
assessments.  These women reported significantly different reactions to the prep sessions 
(and the treatment overall), F (5, 1) = 601.09, p = .031, 
2
p = 1.00, Achieved power = 
.08.  Dropouts reported that they found prep-sessions to be “somewhat” logical (M = 4.5, 
SD = 3.54) and “very little” helpful (M = 3.50, SD = 2.12).  A similar breakdown was 
observed in the self-reported utilization of prep sessions in later treatment.  Treatment 
completers reported that they “often” drew on prep sessions in treatment (M = 4.20 of 5, 
SD = .45) and found that prep sessions helped them to stay motivated in treatment 
“somewhat” to “a good deal” (M = 3.60 of 5, SD = 1.14).  The two women who 
terminated prematurely reported that they drew on prep sessions “a little” to “somewhat” 
in treatment (M = 2.50, SD = .71) and found that prep sessions helped them to stay 
motivated in treatment “somewhat” (M = 3.00, SD = 1.41).  It is noteworthy that only 2 
of 8 dropouts completed a follow-up assessment, but that those women also reported that 
they used MI less during treatment than CPT completers and found MI to be less logical 
and less helpful.   
Given the low number of follow-up assessments completed by MI dropouts, 
participant reactions at the first CPT session were also reviewed.  At that time, 
participants who went on to drop out did not endorse significantly different views of 
treatment than individuals who went on to complete treatment, F (7, 8) = .38, p = .891, 
2
p = .25, Achieved power = .14.  Univariate analyses also revealed no significant 
differences between groups on treatment ratings at CPT session 1.  Thus, participants did 
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not differ on their reported views of treatment early in treatment, but at follow-up, 
women who completed treatment reported MI, and treatment overall, to be more helpful 
than those who did not complete treatment.   
When asked to describe their reactions to the first three preparation sessions, 
participants reported: 
“They gave me a sense of where we were headed, which helped me feel in control. It 
also helped knowing there were logical specific steps, not just talking aimlessly.” 
“At first I didn't understand why there was prep sessions or talk about the cons of 
change. But this allowed for me to be prepared for a lot of the cons. They made me 
motivated to keep coming back.” 
“I was confused about the purpose. It was a little scary because I thought it meant it 
was going to be really hard.” 
“Made me hopeful and helped me to clarify for myself why exactly I want to get 
better.” 
When asked to describe the impact that drawing on prep sessions during later 
treatment had on their therapy experiences, participants reported: 
“When we identified the cons of changing and the pros in the prep sessions, it 
motivated me by showing how it would be better to change and be prepared for 
change than staying the same. It gave me goals to work towards.” 
“It gave me more confidence. It meant I had visible ways of seeing my own 
improvement.” 
“I looked back at the worksheets and notes of those first sessions when the treatment 
continued.” 
Participant responses demonstrate a range of experiences with the MI prep 
sessions.  Respondents describe the sessions as helping them to feel “motivated”, 
“hopeful”, and “in control”.  They also note drawing on MI work, including their goals 
and confidence, during CPT.  However, participants also noted feeling “confused” at first 
by the prep sessions.  Unfortunately, study dropouts did not provide written reactions to 
the MI sessions.  Thus, the current data cannot speak to the qualitative experience of 
women who did not complete treatment. 
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Hypothesis 7.  Finally, traditional psychotherapy outcomes were assessed in the 
MI pilot sample.  Descriptive statistics revealed a high dropout rate in the MI study over 
the course of the trial, such that 8 of 17 women terminated therapy (MI or CPT) 
prematurely (47.06%).  This rate was high in comparison to the established literature (see 
Table 3).  Interestingly, no participants dropped out of treatment during the course of MI.  
One participant never initiated treatment (the only participant who was in the pre-
contemplation stage at pre-treatment).  All other participants, even those who were later 
removed from analyses for meeting exclusion criteria, completed MI.  Dropouts in the MI 
study prematurely terminated from CPT between sessions 1 and 9 (3 at session 1, 1 at 
session 3, 2 at session 5, and 1 at session 9).   
7a) Chi-square analysis indicated the MI study dropout rate was not statistically 
different from the Hypnosis study conditions, wherein 23 of 48 SM+CPT participants 
(47.92%) and 18 of 44 Hyp+CPT participants (40.91%) dropped out prematurely from 
therapy (see Table 4).  Regarding average number of CPT sessions completed prior to 
dropout, MI participants did not differ from SM+CPT participants; however, Hyp+CPT 
participants differed from both comparison groups, such that they were significantly more 
likely never to attend a single CPT session (see Table 4).   
Hypothesis 8.  MI study participants demonstrated good, but varying engagement 
on process measures.  Figure 5 displays the mean minutes of daily homework for 
participants in the MI study by treatment completer status across CPT sessions.  A visual 
analysis shows a broad range of engagement in homework in both the treatment dropout 
and completer groups.  Participants also varied in other potential markers of treatment 
engagement, including their views of treatment and the number of sessions missed during 
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the CPT protocol (see Table 4).  
8a) Next, we tested the hypothesis that MI participants would demonstrate more 
engagement on process measures related to ambivalence than participants in the 
Hypnosis study, who did not receive MI.  As can be seen in Table 4, there was no 
difference across conditions on number of sessions missed during CPT (for completers) 
or on average CPT homework engagement.  However, participants did vary in their 
treatment expectations across conditions, F (8, 158) = 2.42, p = .017, 
2
p = .11, Achieved 
power = .63.  No univariate differences on specific views of treatment reached 
significance, suggesting that participants across conditions varied in their pattern of 
treatment expectation (see Table 5).  Contrary to hypotheses SM+CPT participants 
appeared to be non-significantly higher on the view of CPT as logical at CPT session 1, 
whereas MI+CPT participants were non-significantly higher on the view that they would 
recommend this treatment to a friend.  These results are considered tentative given the 
limited power and non-statistically significant univariate results, but may indicate 
differential treatment credibility following different preparatory treatment experiences. 
Hypothesis 9.  Finally, repeated measures MANOVAs were used to assess gains 
between pre-treatment and follow-up on primary symptom measures (CAPS, PDS, and 
BDI-II).  First, a MANOVA of the ITT MI+CPT sample revealed a strong and significant 
effect of time from pre-treatment to follow-up, F (3, 14) = 10.26, p = .001, 
2
p = .69, 
Achieved power = .49.  Univariate analyses also demonstrated a large and significant 
effect of time across measures (
2
p: CAPS = .63; PDS = .40; BDI-II = .43).  Consistently, 
the MI+CPT completer sample revealed a strong and significant effect of time from pre-
treatment to follow-up, F (3, 6) = 5.38, p = .039, 
2
p = .73, Achieved power = .26, with a 
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slightly larger effect of time across univariate measures (
2
p: CAPS = .68; PDS = .54; 
BDI-II = .48).  Regarding diagnostic status, 8 of 17 MI+CPT ITT participants (47.06%) 
and 3 out of 9 MI+CPT treatment completers (33.33%) remained PTSD positive at 
follow-up.  Of note, LOCF was used for a single missing MI+CPT completer and for 6 of 
8 MI dropouts who did not complete follow-up assessments, drawing on final session 
PDS and BDI-II and pre- or mid-treatment CAPS scores as available.  These results 
demonstrate that the MI+CPT intervention effectively reduced primary symptoms of 
PTSD and depression.  As expected, results were more robust for treatment completers 
and non-response rates were consistent with the broader literature (see Table 3). 
9a) Repeated measures MANOVAs were then used across conditions to test the 
hypothesis that MI+CPT participants would experience greater gains between pre-
treatment and follow-up on primary symptom measures than individuals who completed 
CPT without MI (i.e., Hypnosis study participants).  ITT MANOVA revealed a 
significant effect of time across conditions, F (3, 104) = 41.98, p < .0001, 
2
p = .55, 
Achieved power = .99.  Univariate analyses demonstrated a large and significant effect of 
time across conditions for all measures (
2
p: CAPS = .55; PDS = .42; BDI-II = .38).   
Contrary to hypotheses, participants did not appear to change differentially across 
conditions, such that the time*condition interaction effect was not statistically different 
and was associated with a small effect size, F (6, 208) = .84, p = .541, 
2
p = .02, 
Achieved power = .63.  Univariate tests revealed that each of the primary outcome 
measures was associated with a small and non-significant interaction effect (
2
p: CAPS = 
.01; PDS = .01; BDI-II = .02).  PTSD diagnostic status was also assessed at follow-up.  
ITT completers evidenced a high non-response rate across samples (MI+CPT = 47.06%, 
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SM+CPT = 39.58%, Hyp+CPT = 43.18%), with a non-significant between groups 
difference, 
2
 (1, N = 109) = .32, p = .854, Cramer’s V = .05, Achieved power = .81. 
Completer results revealed a similar picture (see Table 6).  All Hypnosis study 
completers completed at least one post-treatment assessment (25 SM+CPT and 26 
Hyp+CPT) and all but 1 of 9 MI+CPT completed a post-treatment assessment.  No pre-
treatment differences were associated with DVs.  MANOVA again revealed a significant 
effect of time across conditions, such that participants across conditions demonstrated 
clinically significant gains on all primary symptom measures.  Again, contrary to 
hypotheses, participants did not appear to change differentially across conditions, such 
that the time*condition interaction effect was not statistically different and was 
associated with a small effect size.  Thus, all those who completed treatment, regardless 
of condition, experienced similar gains.  Regarding diagnostic status, the MI study non-
response rate for treatment completers (33.33%) was non-significantly higher than the 
SM+CPT (8.00%) and Hyp+CPT (19.23%) treatment completer non-response rates, 
2
 
(2, N = 60) = 3.26, p = .194, Cramer’s V = .23, Achieved power = .54.  Taken together 
with the MI study pilot results, the comparison Hypnosis analyses revealed that MI study 
participants experienced significant and meaningful change in primary symptoms over 
the study period, but did not show enhanced change as compared to participants in the 
Hypnosis study conditions. 
 
I. Discussion 
This pilot study aimed to assess the augmentation of Cognitive Processing 
Therapy (CPT) with three preparatory sessions of Motivational Interviewing (MI), to 
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decrease dropout and non-response by decreasing ambivalence and increasing readiness 
to change, before and during trauma-focused treatment.  First and foremost, the pilot 
nature of the current study cannot be overstated.  Statistical power was limited by the 
pilot sample size.  However, these analyses were consistent with several recent pilot trials 
(Constantino et al., 2008; Tuerk et al., 2010) and are hoped to provide valuable 
preliminary data to the literature.  Every effort was made to maximize the strengths of the 
current study and to account for statistical power limitations.  The use of effect sizes is in 
line with recent pilot trials and is proposed to be a better estimate of change in limited 
samples (Constantino et al., 2008).  Toward this end, current data analyses incorporated 
tests of statistical significance as well as consideration of achieved power and effect sizes 
in an effort to best represent study data.   
This study represents the first empirical investigation of MI used in an individual 
format as an augmentation for trauma-focused treatment.  Several important results 
emerged from these pilot data that may be meaningful for future research and for clinical 
practice.  First, even among this treatment-seeking sample, participants presented for 
treatment with a range of readiness to change (RTC).  Second, the MI intervention 
appeared to be well tolerated within the pilot sample.  It is particularly noteworthy that all 
participants who began MI completed MI, indicating that the preparatory sessions were 
well tolerated in the pilot sample.  Moreover, CPT treatment completers evaluated the MI 
sessions as helpful and indicated that they drew on preparatory work for motivation 
during treatment.  Third, broadly speaking, MI produced the anticipated associations with 
changes on RTC.  This result was not as robust as anticipated, but provides initial 
evidence that readiness does increase with MI for trauma-survivors.  Fourth, as 
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anticipated, participants evidenced unique trajectories of ambivalence throughout 
treatment.  MI was utilized throughout the CPT protocol across cases.  Yet, although 
clinically useful, MI did not produce immediate effects on RTC when implemented 
within CPT.  Moreover, MI was not associated with lower dropout or increased 
engagement or symptom outcomes.  We will consider these points in turn within the 
context of the comparison results and broader treatment literature. 
Influence of MI on RTC measures 
The primary aim of this study was to investigate the ability of MI to influence 
ambivalence and RTC prior to CPT.  As anticipated, MI pilot participants evidenced 
change over time on the established RTC measure (URICA).  However, contrary to 
expectations, Hypnosis comparison analyses also revealed a pattern of change over the 
pre- to mid-treatment period on the URICA.  This finding indicates that MI did not have 
a robust differential effect on RTC.  This unexpected result may reflect the sheer impact 
of becoming involved in treatment, which is in itself taking action toward change, and/or 
the effect of treatment on RTC.  For example, it is possible that individuals in all 
conditions increased in RTC due to increases in hope following assessment.  Similarly, 
participants may have experienced increases in self-efficacy with progress during sleep 
directed hypnosis training in the Hyp+CPT condition or with symptom monitoring in the 
SM+CPT condition, which has been noted to produce amelioration of PTSD symptoms in 
previous studies (Galovski et al., 2012).  Thus, although pilot participants did evidence 
change in RTC over the preparatory sessions, it appears this effect may not have been 
unique to the MI intervention.   
Although counter to predictions, the finding that MI may not have had a unique 
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effect on RTC is consistent with limited previous studies in the anxiety disorders.  
Murphy et al. (2009) also did not find differential change on the URICA between MI and 
psychoeducation-based treatments in their PTSD-positive veteran sample.  Their study 
did not report change over time across conditions, so it remains unknown if those 
interventions were associated with change over time on RTC.  Only one other study has 
measured pre- to post-intervention change in a PTSD-positive sample.  Rooney et al.’s 
(2005) treatment study did not find change in RTC (using the URICA) or in the pros and 
cons of change following a 2-day psychoeducation-based preparation group with 
veterans.  However, the duration may have been too brief to detect meaningful changes.  
Interestingly, they found that individuals increased on RTC over the course of trauma-
focused treatment, again supporting the hypothesis that RTC may also be impacted by 
change-oriented interventions.  Taken together with the current results, previous studies 
support a non-specific effect of treatment on RTC.  Given the limitations to these initial 
trials, it remains difficult to draw firm conclusions regarding the impact of MI 
interventions on RTC.  Yet, thus far, MI has not demonstrated robust differential change 
on RTC prior to CBTs for PTSD as compared to non-MI interventions.  Future study is 
needed to assess the impact of other interventions on RTC, possibly through theoretically 
related mechanisms (e.g., increase in self-efficacy via symptoms change in related 
preparatory interventions or trust in the therapist, etc.).  It is also important to consider 
the high RTC of participants in the current trial and comparison conditions, each of 
which had only a single participant in the pre-contemplation phase.  The current results 
may not generalize to populations with lower RTC for PTSD (e.g., substance use 
treatment programs, primary care, domestic violence shelters, etc.), in which case MI 
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may have a unique impact on enhancing readiness. 
Interestingly, views of CPT changed for a subset of the MI sample.  Specifically, 
those who went on to complete treatment demonstrated a significant difference in the 
view of CPT as logical following MI as compared those who did not go on to complete 
CPT.  Other views of treatment and fear of treatment also demonstrated a differential 
pattern of change between those who went on to complete CPT and those who did not, 
but did not reach significance and suffered from low statistical power.  Moreover views 
and fear of treatment demonstrated large but non-significant change over the course of 
the MI sessions (p = .368, 
2
p = .38).  The issue of why participants may have evidenced 
differential change will be considered further below.  Thus, although the finding of 
change in views and fear of treatment are tentative, they are consistent with previous 
studies.  Specifically, Tolin and Maltby’s (2008) study with treatment refusing OCD 
participants indicated that change in fear of treatment was the only significant predictor 
of entrance into therapy in their sample.  Similarly, Westra et al. (2006) reported that 
increasing treatment expectations were a significant predictor of homework compliance, 
which predicted treatment outcomes in their mixed anxiety sample.  These results 
indicate that treatment expectations, or credibility, and fear of treatment may be 
important markers for dropout, and support that these markers may be amenable to 
change using MI.  These markers are easy to assess, measured by five total items in the 
present sample, and thus could make a useful clinical tool if these tentative results are 
replicated.  Future research is needed to replicate these results.   
CPT Augmentation 
A secondary aim of this study was to investigate the utility of augmenting CPT 
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with MI components throughout the CPT protocol.  MI was used for nearly all 
participants at some point during the CPT intervention, with six instances in which MI 
was a more primary intervention (> 5 minutes).  MI was utilized at times when 
participants voiced ambivalence regarding treatment, typically either regarding coming to 
sessions or completing home practice.  Although the determination to MI use within CPT 
was made based upon clinical considerations, the results supported that participants 
reported significantly higher contemplation on the SOC marginally significantly higher 
pre-contemplation on the URICA at sessions where MI was utilized as opposed to at 
sessions when it was not utilized.  This finding lends some support to the ability of RTC 
measures to assess within session change; however, these measures are not clinically 
useful markers of ambivalence during the session, as they require specific scoring of over 
30 items. 
Despite the perceived clinical utility for the augmentation of CPT with MI 
elements, there were no significant changes in measures of RTC following MI use during 
CPT.  It is possible that available RTC measures, which were not designed to assess such 
small scale fluctuations in ambivalence, may not be the best indicator of the successful 
use of MI during CPT.  This is tentatively supported by the lack of robust differences in 
RTC scores between sessions where the MI therapist observed ambivalence.  Moreover, 
it is possible that MI utilization during CPT had a smaller or less direct effect on RTC, 
which was not detectable in the current analyses.  Future research could usefully target 
both more easily readable session-by-session ambivalence/RTC measures, as well as the 
ways in which therapists address ambivalence in session with MI or other therapeutic 
tools. 
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Attrition, Engagement, and Treatment Outcomes 
The final aim of the current study was to assess the tolerability of MI+CPT and to 
test the overall efficacy of the MI+CPT intervention on conventional trauma-focused 
treatment outcomes, dropout and treatment engagement and primary symptom outcomes.  
As noted, the MI pilot intervention appears to have been well tolerated by those who 
completed treatment.  Moreover, study participants also indicated that they found the 
prep sessions to be very helpful and reflected that information gathered during the MI 
sessions helped maintain motivation during the trauma-focused work.  Many participants 
indicated that the MI sessions allowed them to clarify goals and “get motivated” for 
treatment.  Despite extensive outreach efforts and the addition of compensation for a final 
assessment, only two women completed follow-ups after dropping out of the study.  
Those two women provided limited information regarding their experience of treatment, 
but did report lower satisfaction with the therapy than treatment completers.  As such, the 
current data cannot speak to the overall tolerability of the MI plus CPT intervention as 
experienced by those who did not to complete treatment.  It is noteworthy that all 
participants who began MI completed the MI preparatory sessions and that participant 
who went on to dropout rated the intervention similarly following the MI sessions, again 
indicating tolerability of the preparatory intervention.  However, like those who 
terminated prematurely from the Hypnosis study, MI study participants who later 
dropped out of CPT indicated that they were less satisfied with therapy at follow-up.  
This is an important consideration given the larger than expected dropout rate in the pilot 
study.  It is possible that the addition of MI to the CPT protocol had differential 
effectiveness for survivors (e.g., depending upon initial RTC, primary symptom 
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presentation, etc.), which may be a fruitful area of research for future study.   
Regarding dropout, the use of MI did not appear to reduce dropout in the present 
sample, which had an observed dropout rate of 47.06%.  The finding that all participants 
who began MI completed the MI preparatory sessions indicates that MI was well 
tolerated, but was not associated with increased CPT completion.  When looking at the 
broader literature, the MI study dropout rate was at the high end of all active treatments, 
which average around 18%  (Imel et al., 2013) and range from 0 to 54% (Schottenbauer 
et al., 2008).  This range is similar when reviewing prior CPT studies, which reported 
dropout rates ranging from 26.79% (Resick et al., 2002) to 44.57% in the Hypnosis study 
(Galovski, Elwood, Blain, & Mott, In preparation).  Taken together, even considering the 
limited statistical power produced by the smaller MI sample size, it is clear that MI did 
not improve upon observed dropout rates in the current study.   
Similarly, MI study participants demonstrated good engagement during treatment, 
but did not evidence more treatment engagement on process measures (including 
homework completion and session attendance), than individuals in the comparison 
Hypnosis study.  One exception was noted, such that MI participants indicated they 
would be more likely to recommend CPT to a friend than Hypnosis study participants.  
This item has been found to be a reliable indicator of treatment credibility in the literature 
(Borkovec & Nau, 1972).  There was limited evidence that MI may have had some 
impact on views of treatment (i.e., being more likely to recommend CPT to a friend) as 
compared to Hypnosis study completers (above), but non-significant evidence that MI 
had an overall impact on treatment expectations during the preparation sessions.  As 
discussed, CPT treatment completers evidenced differential change across MI on views 
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of CPT as logical from those who went to dropout, but it is unclear why dropouts did not 
evidence similar increases in expectations.  Moreover, no comparison data regarding 
treatment expectations was available for the Hypnosis study conditions at pre-treatment.  
Thus, it remains possible other active and control treatments may have a similar effect on 
enhancing credibility, which is supported by the evidence that participants in non-MI 
conditions also evidenced change in RTC over the pre-treatment period. 
Although MI+CPT participants evidenced significant gains on symptom 
outcomes acoss CPT, contrary to hypotheses, MI study participants had largely 
equivalent outcomes to Hypnosis study completers and to PTSD outcomes in the broader 
literature.  Specifically, symptom outcomes were not statistically different between the 
two studies, with participants across samples evidencing improvement on clinician and 
self-rated PTSD symptoms and on self-rated depressive symptoms.  Regarding the 
broader literature, Schottenbauer et al. (2008) reviewed 55 studies and reported a range of 
non-response rates (i.e., PTSD positive diagnostic status).  Specifically, looking at 3-
month follow-up after active individual-format trauma-focused treatments, PTSD 
positive rates ranged from 4.00% (Galovski et al., 2012) to 45.00% (Foa et al., 1991).  
Thus, the MI study PTSD positive rate at follow-up (33.33%) is within range of previous 
samples of active, trauma-focused, individual format treatments.  This was statistically 
similar with non-response rates found in the overall Hypnosis study and comparable to 
other trials that tests individual CPT used with female sexual assault survivors.  Such 
studies reflected the range of response rates found in the broader PTSD treatment 
response literature, from 16.20% of treatment completers PTSD positive at 3-month 
follow-up (Resick et al., 2002) to 25.9% of the ITT sample PTSD positive at 6-month 
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follow-up (Resick, Galovski et al., 2008).  Overall, the MI study results show a 
remarkably similar profile to the broader trauma-focused treatment literature.  Statistical 
power is a crucial consideration given the limited sample size.  It remains possible that 
MI produced a smaller, non-detectable effect on expectations and engagement in the 
current sample, which may be evidenced by participant ratings of confidence in the 
treatment, such that they would be more likely to recommend it to a friend.  It can only be 
concluded that MI did not produce a large effect on treatment expectations or 
engagement or on symptom and diagnostic outcomes as currently tested.  Before 
considering the limitations and implications of these findings, it is also relevant to 
consider the current results in the context of prior studies that have used MI as a 
preparation to CBT for anxiety. 
Comparison to the Existing MI for Anxiety Literature 
The current results stand apart from some findings in the previous literature of MI 
as a preparation for CBT.  A single study of PTSD-positive male combat veterans who 
attended an MI-based group reported that MI participants attended more total group 
sessions and attended the yearlong program for longer than veterans who received 
psychoeducation (Murphy et al., 2009).  However, Murphy et al.’s study provides a 
limited comparison to the current trial, as it was conducted in the second month of a 
yearlong group-based treatment program.  Additionally, their study did not measure 
PTSD treatment outcomes, thus the nature of continued treatment engagement cannot be 
concluded (e.g., participants may have remained symptomatic longer than in the control 
condition).  The present result of a non-significant increase in dropout also runs counter 
to previous findings in two studies by Westra et al., which found equivalent (2009) and 
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substantially decreased (2006) dropout rates for MI+CBT as compared to WL+CBT.  
Moreover, Westra and colleagues’ studies indicated an increase on homework 
compliance (i.e., engagement) and participant expectations of their ability to master 
symptoms.  Neither of these results was replicated in the current study.  It is noteworthy 
that the current MI study’s dropout rates were larger than in Westra et al.’s trials (2006: 
16% MI+CBT vs. 37% WL+CBT; 2009: 10.53% MI+CBT vs. 15.79% WL+CBT).  This 
difference could be attributable to many factors, including demographic differences 
between predominantly low SES individuals in St. Louis city in the current study and 
individuals who had access to a Toronto suburb without public transportation noted in 
Westra et al.’s (2009) study.  Additionally, Westra et al. targeted mixed anxiety disorders 
(no primary PTSD; 2006) and GAD in their latter study (2009).  The current literature is 
too limited to produce firm conclusions, but indicates that future study could explore the 
impact of target diagnosis on the effectiveness of the MI preparatory interventions.  
The findings that MI preparatory sessions in the current study did not improve 
dropout rates nor overall treatment engagement or primary symptom outcomes thus run 
counter to both initial findings in the anxiety disorders literature and to the broader MI 
literature, and warrant careful consideration.  No study to date has tested the effects of an 
MI-based intervention in a sample of PTSD-positive civilians or as a preparation for 
individual trauma-focused treatment.  Thus, these pilot MI outcomes in this specific 
population are without a true comparison in the literature.  Individuals in the current 
study evidenced mixed readiness to change at pre-treatment, but were actively treatment 
seeking and were largely in the contemplation and preparation/action stages of change.  
In fact, the one participant who scored in the pre-contemplation stage at pre-treatment 
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dropped out before beginning MI.  The MI literature speaks directly to the issue that MI 
should be used to target ambivalence (Miller & Rollnick, 2012), which was not as 
prevalent in the current sample of treatment-seeking individuals.  Thus, it is possible that 
using MI within a high-readiness, treatment-seeking sample is an ill fit, and perhaps that 
MI even had a paradoxical effect for some participants who already established 
motivation.  Clinically speaking, many trauma therapists would also advise a “strike 
while the iron is hot” approach to capitalize on survivors’ willingness to change.  Thus, 
the current study’s approach may thus have run counter to the general wisdom of both MI 
and trauma clinicians.   
By comparison, Westra et al. (2006) also drew from clinic treatment referrals and 
reported a higher rate of dropout than in their 2009 study, which recruited using 
advertisements for individuals who “worry excessively”.  Their studies did not employ an 
RTC measure, so fit with initial stage of change cannot be estimated.  Similarly, Murphy 
et al. (2009) did not report initial stage of change or RTC within their veteran sample, so 
comparisons cannot be drawn.  Moreover, veteran samples are also subject to secondary 
gain issues related to service connected compensation, and thus, may not provide a fitting 
comparison to civilian populations in general.  Interestingly, a recent study using an MI-
based intervention with treatment rejecting OCD participants found promising results, 
such that their MI-based intervention demonstrated clinical significance in increasing 
entrance and completion into CBT for OCD (Tolin & Maltby, 2008).  This latter study 
may also point to the importance of matching interventions to clinical need and 
presentation.  Given the limited nature of the literature regarding MI as a preparatory 
treatment for CBTs for anxiety, conclusions are highly tentative, but suggest 
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consideration of the potential moderational effects of initial RTC and treatment seeking 
status on MI preparatory interventions.  Further research is needed to determine both the 
replicability of the current pilot results, as well as the potential effectiveness of MI within 
anxiety disorder treatment samples of varying RTC. 
Summary, Limitations, and Clinical Considerations 
Generally speaking, the current study produced limited support the proposed 
hypotheses.  Specifically, MI participants did evidence expected changes in RTC over the 
course of MI, but Hypnosis comparison participants also evidenced change in the 
expected directions.  Similarly, there was limited evidence that MI may have had some 
differential impact on views of treatment, as compared to Hypnosis study completers, and 
that views of treatment changed over the course of MI for treatment completers.  But 
there was no significant evidence that MI had an overall impact on treatment 
expectations, pros and cons of treatment, or fear of treatment during the preparation 
sessions in the full sample.  Additionally, although MI was utilized at varying points in 
the CPT protocol to address perceived ambivalence, participants did not evidence 
increases in RTC following sessions where MI was used.  Finally, MI did not appear to 
decrease dropout or increase treatment outcomes in the current sample.  Thus, MI appears 
to have increased RTC and some views of treatment, but may not have had unique effects 
on these outcomes compared to other treatments.  As discussed above, the treatment 
seeking nature and relatively high RTC of the pilot sample may have limited the impact 
of the MI intervention in the current study.  For example, it is likely that these results 
would have been different in a setting with individuals with lower expressed RTC.  This 
factor could also, at least partially, account for discrepant results from previous samples 
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employing MI prior to CBT for anxiety disorders, which did not report initial RTC.   
This study represents the first investigation of MI prior to CBT for PTSD in an 
individual format and the first study of an MI-based intervention in a non-combat sample.  
Moreover, only a handful of studies to date have investigated the use of MI for any 
anxiety disorder.  As such, it is hoped that the current results will add to the growing 
body of literature on MI interventions.  There are, however, several important limitations 
to the current study.  Most notably, this study is limited by the nature of the pilot trial.  As 
such, multiple analyses were subject to low statistical power, and may have been 
underpowered to detect small to medium effects.  Second, the current study lacks a 
randomized comparison sample.  The use of a closely related comparison sample and the 
location of the current results with the extant literature, where available, is hoped to help 
address this concerns; however, a non-randomized control sample, collected at 
overlapping, but non-equivalent time periods does not fully address threats to internal 
validity.  Additionally, the generalizability of this pilot sample is an important 
consideration.  The inclusion of only female assault survivors reduces the generalizability 
of the findings to a smaller sub-sample of trauma survivors.  However, as noted, this sub-
sample of PTSD-positive individuals has not been previously studied regarding MI.  
Finally, the setting of the current study represents another important consideration.  
Women enrolled in the current sample were treatment-seeking, and thus, may already 
have had higher motivation for change.  As such, the effects of MI may be different in 
settings where individuals present as less expressly ready to address PTSD.   
Other methodological considerations may have impacted the current results and 
warrants clinical consideration.  First, meta-analytic research on MI indicated lower 
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effect sizes for manual-guided MI studies versus studies that did not report manual use 
(Hettema et al., 2005).  Thus, the fixed three-session structure and use of a flexible 
protocol for standardization in the present study may have impacted outcomes.  However, 
all participants who began MI completed the MI portion of the protocol and many who 
went on to complete treatment reported that the prep sessions helped them to stay 
motivated and to clarify their treatment goals.  Moreover, the current MI protocol was 
based upon Westra and colleague’s protocol (Westra & Dozois, 2003), which, as 
reviewed, produced effects on treatment engagement and outcomes in their previous 
studies.  Thus, it is unlikely that this approach alone can account for the difference with 
hypothesized outcomes.  It is worth considering how a more flexible approach could be 
utilized in clinical care (e.g., responsive to the needs of the individual client); however, 
the current data cannot speak to these outcomes.  Similarly, it could be argued that 
compensation motivated individuals to complete treatment in the comparison Hypnosis 
study.  However, many studies with compensation reported very high dropout rates 
(Schottenbauer et al., 2008), and all studies which reported payment procedures noted 
that individuals were compensated for assessments regardless of treatment completion.  
Thus, there was no extra incentive for Hypnosis study or other study participants in the 
broader literature to complete treatment to attain compensation.  Additionally, Westra et 
al.’s (2006, 2009) MI-based preparatory treatments did not include direct compensation 
and saw some differential dropout, engagement, and symptom outcomes following 
MI+CBT, which the current study did not replicate.  Here again, this specific 
methodological point likely does not fully account for the discrepancies from the study 
hypotheses. 
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It is also possible that the novice MI status of the study therapist had bearing on 
the current results.  The study therapist reviewed the MI literature in depth, completed 
online and video-based training, received specific MI training from a national 
Motivational Interview Network of Trainers (MINT)-certified trainer, and received 
supervision to ensure the delivery of adherent and competent MI treatment.  The 
literature speaks to the efficacy of brief multi-method training as an empirically 
supported mode of training for MI (Martino, Canning-Ball, Carroll, & Rounsaville, 2011; 
Young & Hagedorn, 2012) and indicates that the use of follow-up consultation enhances 
clinical skill in MI style (Smith et al., 2007).  Moreover, although the novice MI status of 
the therapist introduces a potential threat to internal validity, it increases generalizability 
of the study, as it is unlikely that the majority of trauma-focused therapists seeking to use 
preparatory treatments will be seasoned experts in the use of MI.  It is also noteworthy 
that the MI study therapist achieved relatively low dropout rates in two prior RCTs 
(15.38%, Galovski et al., 2012; 25.00%, Hypnosis study), which provides evidence of 
general efficacy in trauma-focused treatments.  Although every effort was made within 
the financial limitations of the study to ensure adherent and competent MI sessions, it 
remains possible that less seasoned use of MI style is less effective.  This hypothesis 
remains to be tested. 
Bearing the methodological considerations of the present study, and the broader 
limitations to this nascent area of research, in mind, the current findings echo the 
question: What can be done about dropout?  Perhaps it is the nature of this avoidance-
based disorder or the context of survivors’ truly stressful lives that will continue to guide 
dropout no matter how finely tuned or masterfully administered the treatment.  The 
 MI to Augment CPT   93 
 
consistent finding of dropout across time, samples, therapists, and interventions for PTSD 
that would seem to indicate that dropout is a stable part of the recovery process for many 
individuals with PTSD, even those seeking treatment.  Future research is needed to 
investigate continued means to enhance the effectiveness of available treatments for 
PTSD.  Movements towards and away from change (e.g., initiating treatment and 
dropping out) are consistent with ambivalence, and may reflect this natural part of the 
change process for survivors, as the MI literature would predict (Miller & Rollnick, 
2012).  It is also possible that this process unfolds differently for individuals with 
differing psychological concerns, and inherently, cognitive and emotional response 
patterns.  For example, individuals with PTSD, typified by fear-based reactions, may 
respond differential on average to MI or other preparatory interventions than individuals 
with GAD, typified by worry.  This sample was not sufficiently powered to investigate 
these and other potential correlates to differential responses to treatment within the MI 
pilot sample.  Future research is needed to investigate these areas for potential growth. 
Clinically speaking, the current results indicate caution in defaulting to 
preparatory treatments prior to CBTs for PTSD.  MI was well tolerated by those who 
completed treatment, but, in the current study, was associated with a high dropout rate 
during CPT and was not well rated by the two dropout participants who completed 
feedback at follow-up.  Moreover, based on the broader literature, use of MI style would 
clearly be indicated when facing resistance in any therapeutic process.  However, most 
individuals who present for trauma-focused treatment may not need to “get ready”, and 
caution may be warranted in forestalling trauma focused treatments unless ambivalence 
or other contraindications are clearly present. 
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 Table 1 
Pre-treatment Comparisons of the MI and Hypnosis ITT Samples on Demographics, 
Trauma History, and Initial Symptom Presentation. 
 
MI+CPT 
(N = 17) 
SM+CPT 
(n = 48) 
Hyp+CPT 
(n = 44) 
F or 
2 a 
p 
value  
2
p or 
Cramer’s 
V 
b
 
Power 
Age (M, SD) 34.47 
(11.84) 
35.81 
(10.56) 
38.02 
(13.05) 
.70 .500 .01 .63 
Years of education (M, 
SD) 
15.00 
(2.57) 
14.77 
(2.46) 
13.50 
(3.19) 
3.02 .053
t
 .05 .63 
Race    4.75 .093
t
 .21 .81 
Black 11.76% 45.83% 54.55%     
White 70.59% 54.17% 43.18%     
Hispanic ethnicity 11.76% 4.17% 2.27% 2.56 .278 .15 .81 
Marital status    8.50 .075
t
 .20 .71 
Single  35.29% 64.58% 43.18%     
Married/living with 
someone  
35.29% 12.50% 18.18% 
    
Separated/Divorced
/Widowed  
29.41% 22.92% 38.34% 
    
Time since trauma (M, 
SD months) 
237.98 
(174.90) 
187.92 
(173.24) 
198.66 
(184.37) 
.50 .609 .01 .63 
Trauma history        
Experienced CSA 70.59% 73.91% 70.45% 1.05 .592 .10 .81 
Experienced CPA 58.82% 58.70% 59.09% .001 .999 .004 .81 
Experienced ASA 70.59% 69.57% 59.09% 1.33 .514 .11 .81 
Experienced APA 47.06% 69.57% 68.18% 3.03 .220 .17 .81 
Index event    3.45 .750 .13 .64 
CSA 52.94% 41.03% 39.53%     
CPA 11.76% 6.52% 9.30%     
ASA 29.41% 28.26% 25.58%     
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APA 5.88% 23.91% 25.58%     
CAPS total score (M, 
SD) 
75.47 
(17.49) 
75.67 
(16.18) 
79.66 
(14.92) 
.85 .430 .02 .63 
PDS total score (M, 
SD) 
30.47 
(7.07) 
33.42 
(8.45) 
33.11 
(9.34) 
.77 .466 .01 .63 
BDI-II total score (M, 
SD) 
29.76 
(12.01) 
31.17 
(9.84) 
33.50 
(11.07) 
.94 .393 .02 .63 
CAPS sleep item (M, 
SD) 
5.24 
(2.84) 
6.79 
(1.11) 
7.18 
(1.45) 
8.99 .0001* .15 .63 
Stage of Change 
   
4.45 .349 .14 .71 
Pre-contemplation 
6.25% 3.84% 4.35% 
    
Contemplation 
37.50% 38.46% 56.52% 
    
Preparation/Action 
60.00% 57.69% 39.13% 
    
Note. APA = adult physical assault, ASA = adult sexual assault, BDI-II = Beck 
Depression Inventory II, CAPS = Clinician Administered PTSD Scale, CSA = child 
sexual abuse, CPA = child physical abuse, PDS = Posttraumatic Diagnostic Scale.   
a-b
 Chi-square and Cramer’s V statistics are represented for categorical variables; 
ANOVA F and partial eta squared statistics are represented for continuous variables. 
* = p < .05, 
t
 = p < .10. 
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Table 2 
 
Comparison of MI and Hypnosis Study Conditions at Pre- and Mid-Treatment on RTC Measures. 
 MI+CPT 
(N = 16) 
SM+CPT 
(n = 23) 
Hyp+CPT 
(n = 20) 
Time 
(Main Effect) 
Time x TxCond 
(Interaction Effect) 
 
Pre-
treatment 
M (SD) 
Mid-
treatment 
M (SD) 
Pre-
treatment 
M (SD) 
Mid-
treatment 
M (SD) 
Pre-
treatment 
M (SD) 
Mid-
treatment 
M (SD) 
F 
(Time) 
p 2p 
F (Time x 
TxCond) 
p 2p 
URICA Omnibus 
test 
      4.36 .008* .20 1.74 .120 .09 
Pre-contemplation 
Score 
1.41  
(.38) 
1.39   
(.40) 
1.66 
(.55) 
1.52 
(.39) 
1.72   
(.74) 
1.66 
(.57) 
4.33 .042* .08 .61 .548 .02 
Contemplation 
Score 
4.72  
(.26) 
4.57  
(.36) 
4.62 
(.51) 
4.62 
(.50) 
4.48  
(.87) 
4.47 
(.52) 
11.65 .001* .18 1.32 .276 .05 
Preparation/ 
Action Score 
4.05  
(.57) 
4.15  
(.73) 
4.23 
(.59) 
4.24 
(.62) 
4.05  
(.85) 
4.40 
(.43) 
11.32 .001* .18 1.19 .314 .04 
MPSOCQ Omnibus 
test 
      .74 .536 .04 .52 .793 .03 
Pre-contemplation 
Score 
2.17  
(.65) 
2.04  
(.54) 
2.72 
(.73) 
2.28 
(.74) 
2.51  
(.74) 
2.25 
(.90) 
.40 .531 .01 .01 .989 .00 
Contemplation 
Score 
4.23  
(.34) 
4.41  
(.39) 
4.21 
(.48) 
4.22 
(.77) 
4.36  
(.38) 
4.27 
(.56) 
.11 .744 .00 1.19 .314 .04 
Preparation/ 
Action Score 
3.26  
(.79) 
3.43  
(.85) 
3.41 
(.80) 
3.76 
(.64) 
3.68  
(.90) 
4.27 
(.44) 
1.46 .233 .03 .29 .748 .01 
Note. Raw descriptive data are presented.  Covariates are not included in the table for clarity, but years of education, initial sleep 
disturbance severity, and race were included in the corresponding model.  MPSOCQ = Modified Pain Stages of Change Questionnaire, 
URICA = University of Rhode Island Change Assessment.  Achieved power ranged from: URICA, .95 to .99 (main effect) and .37 
(interaction effect); MPSOCQ, .78 to .93 (main effect) and .37 (interaction effect). 
* = p < .05.
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Table 3 
Dropout, Non-response, and Primary Symptoms Outcomes for MI study and Comparison 
Samples in the PTSD Treatment Outcomes Literature. 
 Study Sample Treatment ITT 
N 
Dropout 
rate 
Non-
responder 
rate 
CAPS 
Follow-up  
M (SD) 
PDS 
Follow-up  
M (SD) 
MI Study Female, 
Interpersonal 
assault survivors 
MI+CPT 17 47.06% 33.33% 34.56   
(21.05)
a
 
 
13.89 
(11.20) 
Galovski 
et al, In 
preparation 
(Hypnosis 
Study) 
Female, 
Interpersonal 
assault survivors  
SM+CPT 
 
48 47.92% 
 
8.00% 
 
24.20 
(21.20) 
11.36 
(10.02) 
Hyp+CPT 44 40.91% 19.23% 26.88 
(27.35) 
12.69 
(12.37) 
MI therapist 
(SM+CPT or 
Hyp+CPT) 
8 25.00% 0.00% 
 
17.50 
(17.55) 
6.50  
(7.04) 
Galovski 
et al. 
(2012) 
Male and 
female, 
Interpersonal 
assault survivors 
Variable 
length CPT 
69 27.53% 4.00% 18.68 
(21.56) 
9.92 
(12.36) 
Female, 
Interpersonal 
assault survivors 
MI therapist 
(CPT or 
SMDT) 
13  15.38% 0.00% 19.30 
(14.82) 
10.33 
(8.73) 
Resick et 
al. (2002) 
Female, Rape 
survivors 
CPT 62 26.79% 16.20% 26.78 
(20.03) 
9.75  
(9.04)
d
 
PE 62 27.30% 29.70% 34.27 
(26.89) 
12.72 
(10.98)
d
 
Resick et 
al. 
(2008)
b,c
 
Female, 
Interpersonal 
assault survivors 
CPT 53 34% 25.9%  31.96 
(28.46) 
12.11 
(11.94) 
CPT-C 51 22% 20.7%  31.03 
(27.57) 
12.22 
(11.42) 
WA 55 26% 26.7%  35.90 
(27.09) 
14.62 
(12.57) 
Note. CAPS = Clinician Administered PTSD Scale, CPT = Cognitive Processing 
Therapy, CPT-C = Cognitive Processing Therapy - Cognitive restructuring only, CR = 
Cognitive Restructuring, Hyp = Sleep-directed Hypnosis Training, IE = Imaginal 
Exposure, IR = Imagery Rescripting, MI = Motivational Interviewing, PDS = 
Posttraumatic Diagnostic Scale, PE = Prolonged Exposure, SM = Symptom Monitoring, 
SMDT = Symptom Monitoring Delayed Treatment, WA = Written Account. 
a 
LOCF was used for 1 of 9 completers on the CAPS.  
 MI to Augment CPT   115 
 
b
 Follow-up statistics are reported for completer samples except in Resick et al. (2008), 
which reported only ITT statistics.  
c
 Studies typically employed a 3-month follow-up statistics, except where noted, which 
report a 6-month follow-up. 
d
 The PTSD Symptom Scale (PSS) was reported in place of the PDS. 
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Table 4 
Progression through Treatment by Condition. 
 MI+CPT 
ITT N = 17 
SM+CPT 
ITT n = 48 
Hyp+CPT 
ITT n = 44 
F or 2 b p value  
2
p or 
Cramer’s V c 
Power 
Dropped out 8 23 18 .49 .782 .07 .81 
Dropped out 
before CPT 
1 8 14     
Dropped out 
during CPT  
7 15 4     
M CPT sessions 
before dropout 
3.13   
(3.04) 
2.17   
(2.27) 
.39  
(.78) 
6.39 .004* .22 .63 
M missed sessions 
(completers only) 
4.89  
(3.89) 
4.24  
(4.20) 
3.65  
(3.65) 
1.90 .160 .07 .63 
M homework 
minutes per 
session
 a
 
119.04 
(98.52) 
132.51 
(73.06) 
192.71 
(216.48) 
1.58 .213 .05 .63 
a 
Average minutes of homework per session were computed for participants who completed at least 3 sessions. 
b-c
 Chi-square and Cramer’s V statistics are represented for categorical variables; ANOVA F and partial eta squared statistics are 
represented for continuous variables.   
* = p < .05. 
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Table 5 
Views of Treatment at CPT Session 1. 
 MI+CPT 
(N = 16) 
SM+CPT 
(n = 39) 
Hyp+CPT 
(n = 30) 
F p value  2p 
Power 
CPT logical 7.88  
(1.20) 
8.38  
(.71) 
8.10  
(1.19) 
1.66 .196 .04 .51 
Confidence CPT 
change trauma 
symptoms 
6.56  
(1.32) 
7.31  
(1.66) 
7.37  
(1.30) 
1.78 .175 .04 .51 
Confidence CPT 
change other 
problems 
7.06  
(1.44) 
7.31  
(1.61) 
7.10  
(1.42) 
.23 .797 .01 .51 
Likely to 
recommend CPT 
to friend 
8.38  
(1.03) 
7.74 
(1.50) 
7.87  
(1.31) 
1.25 .292 .03 .51 
Note.  Raw descriptive data are presented for all participants who attended session 1 of CPT.  Data were not available for those who 
dropped out of treatment prior to CPT session 1.  CPT = Cognitive Processing Therapy.  
t
 p < .01. 
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Table 6 
Comparison of MI and Hypnosis Study Completers at Pre-treatment and Follow-up on Primary Symptom Measures. 
 MI+CPT 
(N = 9) 
SM+CPT 
(n = 25) 
Hyp+CPT 
(n = 26) 
Time 
(Main Effect) 
Time x TxCond 
(Interaction Effect) 
 
Pre-
treatment 
M (SD) 
Follow-
up 
M (SD) 
Pre-
treatment 
M (SD) 
Follow-
up 
M (SD) 
Pre-
treatment 
M (SD) 
Follow-
up 
M (SD) 
F 
(Time) 
p value  2p 
F (Time x 
TxCond) 
p value 2p 
Omnibus test       43.82 .0001 .71 .438 .852 .02 
CAPS Total 
Score 
69.11 
(18.02) 
34.56 
(21.05) 
72.16 
(15.71) 
24.20 
(21.20) 
77.96 
(12.96) 
26.88 
(27.35) 
133.82 .0001 .70 1.31 .278 .04 
PDS Total 
Score 
29.33 
(8.94) 
13.89 
(11.20) 
32.12 
(9.02) 
11.36 
(10.02) 
33.69 
(8.28) 
12.69 
(12.37) 
89.86 .0001 .61 .59 .557 .02 
BDI-II Total 
Score 
26.89 
(12.96) 
13.11 
(12.21) 
31.84 
(10.85) 
13.08 
(12.79) 
30.88 
(10.69) 
11.46 
(12.63) 
64.84 .0001 .53 .51 .606 .02 
Note. BDI-II = Beck Depression Inventory II, CAPS = Clinician Administered PTSD Scale, PDS = Posttraumatic Diagnostic Scale. 
Achieved power ranged from: .79 to .86 (main effects) and .95 to .98 (interaction effects). 
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Figure 1.  Pre- to mid-treatment change on overall RTC (URICA scores) for each MI study participant by treatment completer status. 
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Figure 2.  Pre- to mid-treatment change on RTC measures by treatment condition in the ITT sample, using estimated marginal means 
with years of education, initial sleep severity, and race covaried. 
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Figure 3.  Pre- and mid-treatment views of treatment and fear of treatment in the MI ITT sample by treatment completer status. 
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Figure 4. Session by session change in RTC subscale scores (URICA) over CPT for high MI users.  Arrows indicate CPT sessions 
where MI was employed. 
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Figure 5. Reported minutes of homework per day by session for MI study participants by treatment completer status. 
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